,PubChem_CID,Compound Name,standardized_smiles,MW,vDILIConcern,CLASS
0,34869,amineptine,O=C(O)CCCCCCNC1c2ccccc2CCc2ccccc21,337.204179104,vMost-DILI-Concern,active
1,2717,chlormezanone,CN1C(=O)CCS(=O)(=O)C1c1ccc(Cl)cc1,273.022641924,vMost-DILI-Concern,active
2,65679,droxicam,CN1c2c(oc(=O)n(-c3ccccn3)c2=O)-c2ccccc2S1(=O)=O,357.041941452,vMost-DILI-Concern,active
3,65869,ebrotidine,NC(N)=Nc1nc(CSCCN=CNS(=O)(=O)c2ccc(Br)cc2)cs1,475.975848884,vMost-DILI-Concern,active
4,4495,nimesulide,CS(=O)(=O)Nc1ccc([N+](=O)[O-])cc1Oc1ccccc1,308.046692484,vMost-DILI-Concern,active
5,5591,troglitazone,Cc1c(C)c2c(c(C)c1O)CCC(C)(COc1ccc(CC3SC(=O)NC3=O)cc1)O2,441.160993964,vMost-DILI-Concern,active
6,62959,trovafloxacin,NC1[C@@H]2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4-c3ccc(F)cc3F)C[C@H]12,416.109625,vMost-DILI-Concern,active
7,2081,alaproclate,CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1,255.102606496,vMost-DILI-Concern,active
8,3086677,alatrofloxacin mesylate,C[C@H](N)C(=O)N[C@@H](C)C(=O)NC1[C@@H]2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4-c3ccc(F)cc3F)C[C@H]12,558.18385256,vMost-DILI-Concern,active
9,30951,alclofenac,C=CCOc1ccc(CC(=O)O)cc1Cl,226.039671892,vMost-DILI-Concern,active
10,54897,alpidem,CCCN(CCC)C(=O)Cc1c(-c2ccc(Cl)cc2)nc2ccc(Cl)cn12,403.121817716,vMost-DILI-Concern,active
11,2313,bendazac,O=C(O)COc1nn(Cc2ccccc2)c2ccccc12,282.100442308,vMost-DILI-Concern,active
12,39941,benoxaprofen,CC(C(=O)O)c1ccc2oc(-c3ccc(Cl)cc3)nc2c1,301.050570924,vMost-DILI-Concern,active
13,255968,benzarone,CCc1oc2ccccc2c1C(=O)c1ccc(O)cc1,266.094294308,vMost-DILI-Concern,active
14,2333,benzbromarone,CCc1oc2ccccc2c1C(=O)c1cc(Br)c(O)c(Br)c1,421.915318444,vMost-DILI-Concern,active
15,6237,benziodarone,CCc1oc2ccccc2c1C(=O)c1cc(I)c(O)c(I)c1,517.887590244,vMost-DILI-Concern,active
16,60726,bromfenac,Nc1c(CC(=O)O)cccc1C(=O)c1ccc(Br)cc1,333.000055344,vMost-DILI-Concern,active
17,8593,cinchophen,O=C(O)c1cc(-c2ccccc2)nc2ccccc12,249.078978592,vMost-DILI-Concern,active
18,21382,clomacran,CN(C)CCCC1c2ccccc2Nc2ccc(Cl)cc21,300.139326352,vMost-DILI-Concern,active
19,33176,clometacin,COc1ccc2c(C(=O)c3ccc(Cl)cc3)c(C)n(CC(=O)O)c2c1,357.076785672,vMost-DILI-Concern,active
20,2898,cyclofenil,CC(=O)Oc1ccc(C(=C2CCCCC2)c2ccc(OC(C)=O)cc2)cc1,364.167459248,vMost-DILI-Concern,active
21,40399,exifone,O=C(c1cc(O)c(O)c(O)c1)c1ccc(O)c(O)c1O,278.04265266,vMost-DILI-Concern,active
22,28858,fenclozic acid,O=C(O)Cc1csc(-c2ccc(Cl)cc2)n1,252.996427176,vMost-DILI-Concern,active
23,3351,fipexide,O=C(COc1ccc(Cl)cc1)N1CCN(Cc2ccc3c(c2)OCO3)CC1,388.118984832,vMost-DILI-Concern,active
24,3474,glafenine,O=C(OCC(O)CO)c1ccccc1Nc1ccnc2cc(Cl)ccc12,372.087684704,vMost-DILI-Concern,active
25,15250,ibufenac,CC(C)Cc1ccc(CC(=O)O)cc1,192.115029752,vMost-DILI-Concern,active
26,3748,iproniazid,CC(C)NNC(=O)c1ccncc1,179.105862036,vMost-DILI-Concern,active
27,71169,isaxonine,CC(C)Nc1ncccn1,137.095297352,vMost-DILI-Concern,active
28,151166,lumiracoxib,Cc1ccc(Nc2c(F)cccc2Cl)c(CC(=O)O)c1,293.061884556,vMost-DILI-Concern,active
29,6179,mebanazine,CC(NN)c1ccccc1,136.100048384,vMost-DILI-Concern,active
30,6075,mepazine,CN1CCCC(CN2c3ccccc3Sc3ccccc32)C1,310.150369704,vMost-DILI-Concern,active
31,4260,moxisylyte,CC(=O)Oc1cc(C(C)C)c(OCCN(C)C)cc1C,279.18344366,vMost-DILI-Concern,active
32,4472,nialamide,O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1,298.142975816,vMost-DILI-Concern,active
33,3033952,niperotidine,CN(C)Cc1ccc(CSCCN/C(=C\[N+](=O)[O-])NCc2ccc3c(c2)OCO3)o1,434.162390932,vMost-DILI-Concern,active
34,71900,nitrefazole,Cc1nc([N+](=O)[O-])cn1-c1ccc([N+](=O)[O-])cc1,248.054554736,vMost-DILI-Concern,active
35,4528,nomifensine,CN1Cc2c(N)cccc2C(c2ccccc2)C1,238.146998576,vMost-DILI-Concern,active
36,8269,oxyphenisatin,CC(=O)Oc1ccc(C2(c3ccc(OC(C)=O)cc3)C(=O)Nc3ccccc32)cc1,401.126322708,vMost-DILI-Concern,active
37,4723,pemoline,NC1=NC(=O)C(c2ccccc2)O1,176.058577496,vMost-DILI-Concern,active
38,4746,perhexiline,C1CCC(C(CC2CCCCN2)C2CCCCC2)CC1,277.27695012,vMost-DILI-Concern,active
39,71467,phenoxypropazine,CC(COc1ccccc1)NN,166.110613068,vMost-DILI-Concern,active
40,6761,pipamazine,NC(=O)C1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,401.132861068,vMost-DILI-Concern,active
41,35935,pirprofen,CC(C(=O)O)c1ccc(N2CC=CC2)c(Cl)c1,251.071306368,vMost-DILI-Concern,active
42,216235,sitaxsentan,Cc1cc2c(cc1CC(=O)c1sccc1S(=O)(=O)Nc1onc(C)c1Cl)OCO2,454.00600588,vMost-DILI-Concern,active
43,5354,sulcotidil,CCCCCCCCNC(C)C(O)c1ccc(SC(C)C)cc1,337.24393574,vMost-DILI-Concern,active
44,11033,sulfacarbamide,NC(=O)NS(=O)(=O)c1ccc(N)cc1,215.036462148,vMost-DILI-Concern,active
45,5340,sulfathiazole,Nc1ccc(S(=O)(=O)Nc2nccs2)cc1,255.013618528,vMost-DILI-Concern,active
46,38409,ticrynafen,O=C(O)COc1ccc(C(=O)c2cccs2)c(Cl)c1Cl,329.952035096,vMost-DILI-Concern,active
47,65592,tilbroquinol,Cc1cc(Br)c(O)c2ncccc12,236.978925976,vMost-DILI-Concern,active
48,53359,tolrestat,COc1ccc2c(C(=S)N(C)CC(=O)O)cccc2c1C(F)(F)F,357.064648968,vMost-DILI-Concern,active
49,29321,triacetyldiphenolisatin,CC(=O)Oc1ccc(C2(c3ccc(OC(C)=O)cc3)C(=O)N(C(C)=O)c3ccccc32)cc1,443.136887392,vMost-DILI-Concern,active
50,239062,xenazoic acid,CCOC(Nc1ccc(C(=O)O)cc1)C(=O)c1ccc(-c2ccccc2)cc1,375.147058152,vMost-DILI-Concern,active
51,9574101,ximelagatran,CCOC(=O)CN[C@@H](C(=O)N1CC[C@H]1C(=O)NCc1ccc(/C(N)=N/O)cc1)C1CCCCC1,473.26381922,vMost-DILI-Concern,active
52,41987,zimelidine,CN(C)CC=C(c1ccc(Br)cc1)c1cccnc1,316.057510644,vMost-DILI-Concern,active
53,3001322,aplaviroc ,CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2,577.315186096,vMost-DILI-Concern,active
54,32756,dermatan,CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@H](OS(=O)(=O)O)[C@@H]1O[C@@H]1O[C@@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]1O,477.078840036,vMost-DILI-Concern,active
55,6918508,falnidamol ,CN1CCC(Nc2ncc3ncnc(Nc4ccc(F)c(Cl)c4)c3n2)CC1,387.137449508,vMost-DILI-Concern,active
56,50313,fialuridine,O=c1[nH]c(=O)n([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2F)cc1I,371.96184764,vMost-DILI-Concern,active
57,172307,fiduxosin ,COc1cccc2c1[C@@H]1CN(CCCCn3c(=O)[nH]c4c(sc5ncc(-c6ccccc6)nc54)c3=O)C[C@@H]1CO2,555.194025408,vMost-DILI-Concern,active
58,5480200,pafuramidine ,CO/N=C(\N)c1ccc(-c2ccc(-c3ccc(/C(N)=N/OC)cc3)o2)cc1,364.1535405,vMost-DILI-Concern,active
59,153270,pralnacasan ,CCO[C@@H]1OC(=O)C[C@@H]1NC(=O)[C@@H]1CCCN2C(=O)CC[C@H](NC(=O)c3nccc4ccccc34)C(=O)N12,523.206698268,vMost-DILI-Concern,active
60,60919,tasosartan,Cc1nc(C)c2c(n1)N(Cc1ccc(-c3ccccc3-c3nn[nH]n3)cc1)C(=O)CC2,411.180758292,vMost-DILI-Concern,active
61,6437841,acitretin,COc1cc(C)c(/C=C/C(C)=C/C=C/C(C)=C\C(=O)O)c(C)c1C,326.188194692,vMost-DILI-Concern,active
62,2157,amiodarone,CCCCc1oc2ccccc2c1C(=O)c1cc(I)c(OCCN(CC)CC)c(I)c1,645.023689788,vMost-DILI-Concern,active
63,104865,bosentan,COc1ccccc1Oc1c(NS(=O)(=O)c2ccc(C(C)(C)C)cc2)nc(-c2ncccn2)nc1OCCO,551.183854648,vMost-DILI-Concern,active
64,6253,cytarabine,Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)c(=O)n1,243.085520516,vMost-DILI-Concern,active
65,5351166,dacarbazine,CN(C)N/N=C1\N=CN=C1C(N)=O,182.09160894,vMost-DILI-Concern,active
66,28417,danazol,C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=Cc5oncc5C[C@]4(C)[C@H]3CC[C@@]21C,337.204179104,vMost-DILI-Concern,active
67,2952,dantrolene,O=C1CN(N=Cc2ccc(-c3ccc([N+](=O)[O-])cc3)o2)C(=O)N1,314.06511942,vMost-DILI-Concern,active
68,5493381,deferasirox,O=C1C=CC=C/C1=C1\N/C(=C2/C=CC=CC2=O)N(c2ccc(C(=O)O)cc2)N1,373.10625596,vMost-DILI-Concern,active
69,3331,felbamate,NC(=O)OCC(COC(N)=O)c1ccccc1,238.095356928,vMost-DILI-Concern,active
70,3397,flutamide,CC(C)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1,276.072176872,vMost-DILI-Concern,active
71,3767,isoniazid,NNC(=O)c1ccncc1,137.058911844,vMost-DILI-Concern,active
72,47576,ketoconazole,CC(=O)N1CCN(c2ccc(OC[C@@H]3CO[C@@](Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1,530.148760736,vMost-DILI-Concern,active
73,208908,lapatinib,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,580.134732212,vMost-DILI-Concern,active
74,3899,leflunomide,Cc1oncc1C(=O)Nc1ccc(C(F)(F)F)cc1,270.061612188,vMost-DILI-Concern,active
75,126941,methotrexate,CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1,454.171315804,vMost-DILI-Concern,active
76,4178,mexiletine,Cc1cccc(C)c1OCC(C)N,179.131014164,vMost-DILI-Concern,active
77,4449,nefazodone,CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1,469.224452944,vMost-DILI-Concern,active
78,4463,nevirapine,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,266.116761068,vMost-DILI-Concern,active
79,5878,oxandrolone,C[C@]12COC(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O,306.21949482,vMost-DILI-Concern,active
80,9902,oxymetholone,C[C@]12CC(C=O)C(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O,332.235144884,vMost-DILI-Concern,active
81,10113978,pazopanib,Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O,437.163393976,vMost-DILI-Concern,active
82,40926,pentostatin,OCC1OC(n2cnc3c2NC=NC[C@H]3O)CC1O,268.117154992,vMost-DILI-Concern,active
83,657298,propylthiouracil,CCCc1cc(=O)[nH]c(=S)[nH]1,170.05138394,vMost-DILI-Concern,active
84,18283,stavudine,Cc1cn([C@H]2C=C[C@@H](CO)O2)c(=O)[nH]c1=O,224.079706864,vMost-DILI-Concern,active
85,5329102,sunitinib,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C,398.211804324,vMost-DILI-Concern,active
86,4659569,tolcapone,Cc1ccc(C(=O)c2cc(O)c(O)c([N+](=O)[O-])c2)cc1,273.063722452,vMost-DILI-Concern,active
87,3121,valproic acid,CCCC(CCC)C(=O)O,144.115029752,vMost-DILI-Concern,active
88,35370,zidovudine,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,267.096753896,vMost-DILI-Concern,active
89,9915926,eltrombopag olamine,Cc1ccc(-n2[nH]c(C)c(N/N=C3\C=CC=C(c4cccc(C(=O)O)c4)C3=O)c2=O)cc1C,442.164105184,vMost-DILI-Concern,active
90,3002977,maraviroc,Cc1nnc(C(C)C)n1C1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1,513.327917372,vMost-DILI-Concern,active
91,65027,tipranavir,CCC[C@@]1(CCc2ccccc2)CC(=O)C([C@H](CC)c2cccc(NS(=O)(=O)c3ccc(C(F)(F)F)cn3)c2)C(=O)O1,602.206227816,vMost-DILI-Concern,active
92,4649,4-aminosalicylic acid,Nc1ccc(C(=O)O)c(O)c1,153.042593084,vMost-DILI-Concern,active
93,65140,abacavir,Nc1nc(NC2CC2)c2ncn(C3C=C[C@H](CO)C3)c2n1,286.154209196,vMost-DILI-Concern,active
94,441184,acarbose,C[C@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@H](O[C@@H]3[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1N[C@H]1C=C(CO)[C@H](O)[C@H](O)[C@H]1O,645.248013536,vMost-DILI-Concern,active
95,1983,acetaminophen,CC(=O)Nc1ccc(O)cc1,151.063328528,vMost-DILI-Concern,active
96,1986,acetazolamide,CC(=O)Nc1nnc(S(N)(=O)=O)s1,221.988132052,vMost-DILI-Concern,active
97,2082,albendazole,CCCSc1ccc2nc(NC(=O)OC)[nH]c2c1,265.08849772,vMost-DILI-Concern,active
98,2094,allopurinol,O=c1ncnc2[nH][nH]cc1-2,136.038510748,vMost-DILI-Concern,active
99,54841,atomoxetine,CNCC[C@@H](Oc1ccccc1C)c1ccccc1,255.162314292,vMost-DILI-Concern,active
100,60823,atorvastatin,CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(=O)O,558.25300044,vMost-DILI-Concern,active
101,2265,azathioprine,Cn1cnc([N+](=O)[O-])c1Sc1ncnc2nc[nH]c12,277.038193464,vMost-DILI-Concern,active
102,82146,bexarotene,C=C(c1ccc(C(=O)O)cc1)c1cc2c(cc1C)C(C)(C)CCC2(C)C,348.208930136,vMost-DILI-Concern,active
103,56069,bicalutamide,C[C@](O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,430.061040808,vMost-DILI-Concern,active
104,2478,busulfan,CS(=O)(=O)OCCCCOS(C)(=O)=O,246.023180168,vMost-DILI-Concern,active
105,2554,carbamazepine,NC(=O)N1c2ccccc2C=Cc2ccccc21,236.094963004,vMost-DILI-Concern,active
106,2733,chlorzoxazone,O=c1[nH]c2cc(Cl)ccc2o1,168.993056048,vMost-DILI-Concern,active
107,2764,ciprofloxacin,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,331.133219656,vMost-DILI-Concern,active
108,84029,clarithromycin,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,747.476891268,vMost-DILI-Concern,active
109,2801,clomipramine,CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21,314.154976416,vMost-DILI-Concern,active
110,2818,clozapine,CN1CCN(C2=c3ccccc3=Nc3ccc(Cl)cc3N2)CC1,326.129824288,vMost-DILI-Concern,active
111,213039,darunavir,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@@H]12)S(=O)(=O)c1ccc(N)cc1,547.235221524,vMost-DILI-Concern,active
112,3033,diclofenac,O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl,295.016683952,vMost-DILI-Concern,active
113,50599,didanosine,O=c1[nH]cnc2c1ncn2[C@H]1CC[C@@H](CO)O1,236.090940244,vMost-DILI-Concern,active
114,3059,diflunisal,O=C(O)c1cc(-c2ccc(F)cc2F)ccc1O,250.044150556,vMost-DILI-Concern,active
115,39186,diltiazem,COc1ccc([C@@H]2Sc3ccccc3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O)cc1,414.161328312,vMost-DILI-Concern,active
116,3117,disulfiram,CCN(CC)C(=S)SSC(=S)N(CC)CC,296.05093264,vMost-DILI-Concern,active
117,208898,dronedarone,CCCCc1oc2ccc(NS(C)(=O)=O)cc2c1C(=O)c1ccc(OCCCN(CCCC)CCCC)cc1,556.297093508,vMost-DILI-Concern,active
118,60835,duloxetine,CNCC[C@H](Oc1cccc2ccccc12)c1cccs1,297.118735228,vMost-DILI-Concern,active
119,64139,efavirenz,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,315.027390868,vMost-DILI-Concern,active
120,176870,erlotinib,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,393.168856216,vMost-DILI-Concern,active
121,12560,erythromycin,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,733.461241204,vMost-DILI-Concern,active
122,18140,estramustine,CC12CCC3c4ccc(OC(=O)N(CCCl)CCCl)cc4CCC3C1CCC2O,439.168099212,vMost-DILI-Concern,active
123,3279,ethambutol,CCC(CO)NCCNC(CC)CO,204.183778008,vMost-DILI-Concern,active
124,3308,etodolac,CCc1cccc2c3c([nH]c12)C(CC)(CC(=O)O)OCC3,287.152143532,vMost-DILI-Concern,active
125,193962,etravirine,Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)nc(N)c1Br,434.0490712,vMost-DILI-Concern,active
126,60198,exemestane,C=C1C[C@@H]2[C@H](CC[C@]3(C)C(=O)CC[C@@H]23)[C@@]2(C)C=CC(=O)C=C12,296.177630008,vMost-DILI-Concern,active
127,134018,febuxostat,Cc1nc(-c2ccc(OCC(C)C)c(C#N)c2)sc1C(=O)O,316.088163372,vMost-DILI-Concern,active
128,3342,fenoprofen,CC(C(=O)O)c1cccc(Oc2ccccc2)c1,242.094294308,vMost-DILI-Concern,active
129,3365,fluconazole,OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F,306.104065444,vMost-DILI-Concern,active
130,56339,fosphenytoin,O=C1NC(c2ccccc2)(c2ccccc2)C(=O)N1COP(=O)(O)O,362.06677283,vMost-DILI-Concern,active
131,123631,gefitinib,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1,446.152096528,vMost-DILI-Concern,active
132,60750,gemcitabine,Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1,263.071762272,vMost-DILI-Concern,active
133,3463,gemfibrozil,Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1,250.156894564,vMost-DILI-Concern,active
134,441140,griseofulvin,COC1=CC(=O)C[C@@H](C)[C@]12Oc1c(Cl)c(OC)cc(OC)c1C2=O,352.071365944,vMost-DILI-Concern,active
135,3657,hydroxyurea,NC(=O)NO,76.027277368,vMost-DILI-Concern,active
136,5291,imatinib,Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1,493.259008612,vMost-DILI-Concern,active
137,3715,indomethacin,COc1ccc2c(c1)c(CC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1,357.076785672,vMost-DILI-Concern,active
138,5282379,isotretinoin,CC1=C(/C=C/C(C)=C/C=C/C(C)=C\C(=O)O)C(C)(C)CCC1,300.208930136,vMost-DILI-Concern,active
139,55283,itraconazole,CCC(C)n1ncn(-c2ccc(N3CCN(c4ccc(OC[C@H]5CO[C@](Cn6cncn6)(c6ccc(Cl)cc6Cl)O5)cc4)CC3)cc2)c1=O,704.239307056,vMost-DILI-Concern,active
140,3869,labetalol,CC(CCc1ccccc1)NCC(O)c1ccc(O)c(C(N)=O)c1,328.178692628,vMost-DILI-Concern,active
141,3878,lamotrigine,Nc1nnc(-c2cccc(Cl)c2Cl)c(N)n1,255.007850584,vMost-DILI-Concern,active
142,149096,levofloxacin,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23,361.14378434,vMost-DILI-Concern,active
143,4044,mefenamic acid,Cc1cccc(Nc2ccccc2C(=O)O)c1C,241.11027872,vMost-DILI-Concern,active
144,667490,mercaptopurine,S=c1nc[nH]c2nc[nH]c12,152.015667128,vMost-DILI-Concern,active
145,1349907,methimazole,Cn1cc[nH]c1=S,114.025169192,vMost-DILI-Concern,active
146,38853,methyldopa,C[C@](N)(Cc1ccc(O)c(O)c1)C(=O)O,211.084457896,vMost-DILI-Concern,active
147,65833,milnacipran,CCN(CC)C(=O)[C@]1(c2ccccc2)C[C@@H]1CN,246.173213324,vMost-DILI-Concern,active
148,5281021,minocycline,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(=O)C(C(N)=O)C(=O)[C@@]3(O)C(=O)C1C2=O,457.184900204,vMost-DILI-Concern,active
149,9904,nandrolone decanoate,C[C@]12CC[C@@H]3[C@H]4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@@H]2O,274.193280072,vMost-DILI-Concern,active
150,4493,nilutamide,CC1(C)NC(=O)N(c2ccc([N+](=O)[O-])c(C(F)(F)F)c2)C1=O,317.06234046,vMost-DILI-Concern,active
151,5353830,nitrofurantoin,O=C1CN(/N=C\c2ccc([N+](=O)[O-])o2)C(=O)N1,238.033819292,vMost-DILI-Concern,active
152,4543,nortriptyline,CNCCC=C1c2ccccc2CCc2ccccc21,263.167399672,vMost-DILI-Concern,active
153,3034010,orlistat,CCCCCCCCCCC[C@@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)OC(=O)[C@H](CC(C)C)NC=O,495.392373796,vMost-DILI-Concern,active
154,4680,papaverine,COc1ccc(Cc2nccc3cc(OC)c(OC)cc23)cc1OC,339.147058152,vMost-DILI-Concern,active
155,1775,phenytoin,O=C1NC(=O)C(c2ccccc2)(c2ccccc2)N1,252.089877624,vMost-DILI-Concern,active
156,11598201,raltegravir,Cc1nnc(C(=O)NC(C)(C)C2=NC(C(=O)NCc3ccc(F)cc3)C(=O)C(=O)N2C)o1,444.155745992,vMost-DILI-Concern,active
157,5381226,rifampin,CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(c3C2=O)C(=O)/C(=C/NN2CCN(C)CC2)C(NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C4=O,822.405123296,vMost-DILI-Concern,active
158,5070,riluzole,Nc1nc2ccc(OC(F)(F)F)cc2s1,234.00746844,vMost-DILI-Concern,active
159,392622,ritonavir,CC(C)c1nc(CN(C)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1,720.312760636,vMost-DILI-Concern,active
160,216239,sorafenib,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,464.086302712,vMost-DILI-Concern,active
161,5353980,sulfasalazine,O=C(O)C1=C/C(=N/Nc2ccc(S(=O)(=O)Nc3ccccn3)cc2)C=CC1=O,398.068490548,vMost-DILI-Concern,active
162,5352,sulindac,CC1=C(CC(=O)O)c2cc(F)ccc2C1=Cc1ccc([S+](C)[O-])cc1,356.088243624,vMost-DILI-Concern,active
163,2733526,tamoxifen,CC/C(=C(\c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1,371.224914548,vMost-DILI-Concern,active
164,5462516,telithromycin,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C,811.47314328,vMost-DILI-Concern,active
165,5402,terbinafine,CN(CC=CC#CC(C)(C)C)Cc1cccc2ccccc12,291.1986998,vMost-DILI-Concern,active
166,6013,testosterone,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O,288.208930136,vMost-DILI-Concern,active
167,5430,thiabendazole,c1ccc2[nH]c(-c3cscn3)nc2c1,201.036068224,vMost-DILI-Concern,active
168,5472,ticlopidine,Clc1ccccc1CN1CCc2sccc2C1,263.053548128,vMost-DILI-Concern,active
169,5487,tizanidine,Clc1ccc2nsnc2c1NC1=NCCN1,253.018893936,vMost-DILI-Concern,active
170,216237,tolvaptan,Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCC(O)c3cc(Cl)ccc32)c(C)c1,448.15537034,vMost-DILI-Concern,active
171,71616,voriconazole,C[C@@H](c1ncncc1F)[C@](O)(Cn1cncn1)c1ccc(F)cc1F,349.115044728,vMost-DILI-Concern,active
172,5717,zafirlukast,COc1cc(C(=O)NS(=O)(=O)c2ccccc2C)ccc1Cc1cn(C)c2ccc(NC(=O)OC3CCCC3)cc12,575.209006776,vMost-DILI-Concern,active
173,60490,zileuton,CC(c1cc2ccccc2s1)N(O)C(N)=O,236.061948624,vMost-DILI-Concern,active
174,60871,adefovir,CC(C)(C)C(=O)OCOP(=O)(COCCn1cnc2c(N)ncnc21)OCOC(=O)C(C)(C)C,501.198849614,vLess-DILI-Concern,active
175,14956,amphotericin b,C[C@@H]1OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@]2(O)C[C@H](O)[C@@H](C(=O)O)[C@H](C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)C=CC=CC=CC=CC=CC=CC=C[C@H](C)[C@@H](O)[C@H]1C)O2,923.487849876,vLess-DILI-Concern,active
176,6249,ampicillin,CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccccc3)C(=O)N2[C@H]1C(=O)O,349.109627088,vLess-DILI-Concern,active
177,148192,atazanavir,COC(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CN(Cc1ccc(-c2ccccn2)cc1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C,704.389748004,vLess-DILI-Concern,active
178,31101,bromocriptine,CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]c(Br)c(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12,653.22128148,vLess-DILI-Concern,active
179,20824,carbenicillin,CC1(C)S[C@@H]2[C@H](NC(=O)C(C(=O)O)c3ccccc3)C(=O)N2[C@H]1C(=O)O,378.088557296,vLess-DILI-Concern,active
180,498142,carboplatin,O=C(O)C1(C(=O)O)CCC1,144.042258736,vLess-DILI-Concern,active
181,2662,celecoxib,Cc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1,381.075882348,vLess-DILI-Concern,active
182,2708,chlorambucil,O=C(O)CCCc1ccc(N(CCCl)CCCl)cc1,303.079284208,vLess-DILI-Concern,active
183,29029,clindamycin,CCC[C@@H]1C[C@@H](C(=O)NC(C(C)Cl)[C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)N(C)C1,424.179870836,vLess-DILI-Concern,active
184,2796,clofibrate,CCOC(=O)C(C)(C)Oc1ccc(Cl)cc1,242.07097202,vLess-DILI-Concern,active
185,1548955,clomiphene,CCN(CC)CCOc1ccc(/C(=C(\Cl)c2ccccc2)c2ccccc2)cc1,405.185942196,vLess-DILI-Concern,active
186,2812,clotrimazole,Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1,344.108026224,vLess-DILI-Concern,active
187,6098,cloxacillin,Cc1onc(-c2ccccc2Cl)c1C(=O)N[C@@H]1C(=O)N2[C@@H](C(=O)O)C(C)(C)S[C@H]12,435.065569356,vLess-DILI-Concern,active
188,2955,dapsone,Nc1ccc(S(=O)(=O)c2ccc(N)cc2)cc1,248.061948624,vLess-DILI-Concern,active
189,18381,dicloxacillin,Cc1onc(-c2c(Cl)cccc2Cl)c1C(=O)N[C@@H]1C(=O)N2[C@@H](C(=O)O)C(C)(C)S[C@H]12,469.026597004,vLess-DILI-Concern,active
190,148124,docetaxel,CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@@H]12)C3(C)C,807.346605376,vLess-DILI-Concern,active
191,2761171,ethionamide,CCc1cc(C(N)=S)ccn1,166.05646932,vLess-DILI-Concern,active
192,150311,ezetimibe,O=C1[C@H](CC[C@H](O)c2ccc(F)cc2)[C@@H](c2ccc(O)cc2)N1c1ccc(F)cc1,409.148949972,vLess-DILI-Concern,active
193,3339,fenofibrate,CC(C)OC(=O)C(C)(C)Oc1ccc(C(=O)c2ccc(Cl)cc2)cc1,360.112836832,vLess-DILI-Concern,active
194,1548972,fluvastatin,CC(C)n1c(/C=C/[C@H](O)C[C@H](O)CC(=O)O)c(-c2ccc(F)cc2)c2ccccc21,411.184586532,vLess-DILI-Concern,active
195,3446,gabapentin,NCC1(CC(=O)O)CCCCC1,171.125928784,vLess-DILI-Concern,active
196,5464436,gemifloxacin,CO/N=C1/CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,389.14993234,vLess-DILI-Concern,active
197,3672,ibuprofen,CC(C)Cc1ccc(C(C)C(=O)O)cc1,206.130679816,vLess-DILI-Concern,active
198,3825,ketoprofen,CC(C(=O)O)c1cccc(C(=O)c2ccccc2)c1,254.094294308,vLess-DILI-Concern,active
199,3826,ketorolac,O=C(c1ccccc1)c1ccc2n1CCC2C(=O)O,255.089543276,vLess-DILI-Concern,active
200,60825,lamivudine,Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1,229.052112212,vLess-DILI-Concern,active
201,216326,lenalidomide,Nc1cccc2c1CN(C1CCC(=O)NC1=O)C2=O,259.095691276,vLess-DILI-Concern,active
202,3902,letrozole,N#Cc1ccc(C(c2ccc(C#N)cc2)n2cncn2)cc1,285.101445352,vLess-DILI-Concern,active
203,3950,lomustine,O=NN(CCCl)C(=O)NC1CCCCC1,233.093104432,vLess-DILI-Concern,active
204,53232,lovastatin,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21,404.256274252,vLess-DILI-Concern,active
205,4030,mebendazole,COC(=O)Nc1nc2ccc(C(=O)c3ccccc3)cc2[nH]1,295.095691276,vLess-DILI-Concern,active
206,54677470,meloxicam,Cc1cnc(NC(=O)C2C(=O)c3ccccc3S(=O)(=O)N2C)s1,351.034747896,vLess-DILI-Concern,active
207,64778,meropenem,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@H]3CC[C@@H](C(=O)N(C)C)N3)[C@H](C)[C@H]12,383.1514919,vLess-DILI-Concern,active
208,4114,methoxsalen,COc1c2occc2cc2ccc(=O)oc12,216.042258736,vLess-DILI-Concern,active
209,6010,methyltestosterone,C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C,302.2245802,vLess-DILI-Concern,active
210,4205,mirtazapine,CN1CCN2c3ncccc3Cc3ccccc3C2C1,265.157897608,vLess-DILI-Concern,active
211,4212,mitoxantrone,O=C1c2c(O)ccc(O)c2C(=O)c2c(NCCNCCO)ccc(NCCNCCO)c21,444.200884616,vLess-DILI-Concern,active
212,4236,modafinil,NC(=O)C[S+]([O-])C(c1ccccc1)c1ccccc1,273.08234972,vLess-DILI-Concern,active
213,8982,nafcillin,CCOc1ccc2ccccc2c1C(=O)N[C@@H]1C(=O)N2[C@@H](C(=O)O)C(C)(C)S[C@H]12,414.124942804,vLess-DILI-Concern,active
214,1302,naproxen,COc1ccc2cc(C(C)C(=O)O)ccc2c1,230.094294308,vLess-DILI-Concern,active
215,4485,nifedipine,COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1ccccc1[N+](=O)[O-],346.116486296,vLess-DILI-Concern,active
216,4539,norfloxacin,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,319.133219656,vLess-DILI-Concern,active
217,4583,ofloxacin,CC1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23,361.14378434,vLess-DILI-Concern,active
218,6196,oxacillin,Cc1onc(-c2ccccc2)c1C(=O)N[C@@H]1C(=O)N2[C@@H](C(=O)O)C(C)(C)S[C@H]12,401.104541708,vLess-DILI-Concern,active
219,4614,oxaprozin,O=C(O)CCc1nc(-c2ccccc2)c(-c2ccccc2)o1,293.10519334,vLess-DILI-Concern,active
220,34312,oxcarbazepine,NC(=O)N1c2ccccc2CC(=O)c2ccccc21,252.089877624,vLess-DILI-Concern,active
221,5852,penicillamine,CC(C)(S)[C@@H](N)C(=O)O,149.051049592,vLess-DILI-Concern,active
222,4735,pentamidine,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,340.189926008,vLess-DILI-Concern,active
223,4748,perphenazine,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,403.148511132,vLess-DILI-Concern,active
224,4763,phenobarbital,CCC1(c2ccccc2)C(=O)NC(=O)NC1=O,232.084792244,vLess-DILI-Concern,active
225,4829,pioglitazone,CCc1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1,356.1194635,vLess-DILI-Concern,active
226,5280452,piroxicam,CN1C(C(=O)Nc2ccccn2)C(=O)c2ccccc2S1(=O)=O,331.062676896,vLess-DILI-Concern,active
227,54687,pravastatin,CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(=O)O)[C@H]21,424.246103492,vLess-DILI-Concern,active
228,4915,procarbazine,CNNCc1ccc(C(=O)NC(C)C)cc1,221.152812228,vLess-DILI-Concern,active
229,1046,pyrazinamide,NC(=O)c1cnccn1,123.04326178,vLess-DILI-Concern,active
230,4993,pyrimethamine,CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1,248.082874096,vLess-DILI-Concern,active
231,5002,quetiapine,OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1,383.16674804,vLess-DILI-Concern,active
232,8549,quinine,C=C[C@H]1CN2CCC1C[C@H]2[C@H](O)c1ccnc2ccc(OC)cc12,324.183778008,vLess-DILI-Concern,active
233,77999,rosiglitazone,CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1,357.114712468,vLess-DILI-Concern,active
234,6439133,rosuvastatin,CC(C)c1nc(N(C)S(C)(=O)=O)nc(-c2ccc(F)cc2)c1/C=C/[C@H](O)C[C@@H](O)CC(=O)O,481.168284836,vLess-DILI-Concern,active
235,5161,salsalate,O=C(Oc1ccccc1C(=O)O)c1ccccc1O,258.05282342,vLess-DILI-Concern,active
236,60787,saquinavir,CC(C)(C)NC(=O)[C@@H]1CC2CCCCC2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1,670.3842687,vLess-DILI-Concern,active
237,54454,simvastatin,CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21,418.271924316,vLess-DILI-Concern,active
238,9354,succimer,O=C(O)C(S)C(S)C(=O)O,181.970750672,vLess-DILI-Concern,active
239,34698,teniposide,COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5COC(c6cccs6)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O,656.156362084,vLess-DILI-Concern,active
240,464205,tenofovir,C[C@H](Cn1cnc2c(N)ncnc21)OCP(=O)(O)O,287.078340558,vLess-DILI-Concern,active
241,5353990,tetracycline,CN(C)C1C(=O)C(C(N)=O)C(=O)C2(O)C(=O)C3C(=O)c4c(O)cccc4C(C)(O)C3CC12,444.153265728,vLess-DILI-Concern,active
242,2723601,thioguanine,Nc1nc(=S)c2[nH]cnc2[nH]1,167.02656616,vLess-DILI-Concern,active
243,5453,thiotepa,S=P(N1CC1)(N1CC1)N1CC1,189.048955014,vLess-DILI-Concern,active
244,119607,valdecoxib,Cc1onc(-c2ccccc2)c1-c1ccc(S(N)(=O)=O)cc1,314.072513308,vLess-DILI-Concern,active
245,2520,verapamil,COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC,454.283157696,vLess-DILI-Concern,active
246,445354,vitamin a,CC1=C(/C=C/C(C)=C/C=C/C(C)=C/CO)C(C)(C)CCC1,286.22966558,vLess-DILI-Concern,active
247,71158,acamprosate,CC(=O)NCCCS(=O)(=O)O,181.040878832,vLess-DILI-Concern,active
248,1978,acebutolol,CCCC(=O)Nc1ccc(OCC(O)CNC(C)C)c(C(C)=O)c1,336.204907376,vLess-DILI-Concern,active
249,2022,aciclovir,Nc1nc2c(ncn2COCCO)c(=O)[nH]1,225.086189212,vLess-DILI-Concern,active
250,2092,alfuzosin,COc1cc2nc(N(C)CCCNC(=O)C3CCCO3)nc(N)c2cc1OC,389.206304344,vLess-DILI-Concern,active
251,2099,alosetron,Cc1[nH]cnc1CN1CCc2c(c3ccccc3n2C)C1=O,294.148061196,vLess-DILI-Concern,active
252,2118,alprazolam,Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2,308.082874096,vLess-DILI-Concern,active
253,16231,amiloride,NC(N)=NC(=O)c1nc(Cl)c(N)nc1N,229.047885556,vLess-DILI-Concern,active
254,2160,amitriptyline,CN(C)CCC=C1c2ccccc2CCc2ccccc21,277.183049736,vLess-DILI-Concern,active
255,2162,amlodipine,CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl,408.14519958,vLess-DILI-Concern,active
256,33613,amoxicillin,CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccc(O)cc3)C(=O)N2[C@H]1C(=O)O,365.104541708,vLess-DILI-Concern,active
257,2187,anastrozole,CC(C)(C#N)c1cc(Cn2cncn2)cc(C(C)(C)C#N)c1,293.164045608,vLess-DILI-Concern,active
258,2249,atenolol,CC(C)NCC(O)COc1ccc(CC(N)=O)cc1,266.163042564,vLess-DILI-Concern,active
259,55185,azithromycin,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)C(C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,748.508525744,vLess-DILI-Concern,active
260,2284,baclofen,NCC(CC(=O)O)c1ccc(Cl)cc1,213.055656304,vLess-DILI-Concern,active
261,5362124,benazepril,CCOC(=O)[C@H](CCc1ccccc1)N[C@H]1CCc2ccccc2N(CC(=O)O)C1=O,424.199821996,vLess-DILI-Concern,active
262,2315,bendroflumethiazide,NS(=O)(=O)c1cc2c(cc1C(F)(F)F)NC(Cc1ccccc1)NS2(=O)=O,421.037782588,vLess-DILI-Concern,active
263,444,bupropion,CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1,239.107691876,vLess-DILI-Concern,active
264,2541,candesartan,CCOc1nc2cccc(C(=O)O)c2n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1,440.1596885,vLess-DILI-Concern,active
265,44093,captopril,C[C@H](CS)C(=O)N1CCC[C@H]1C(=O)O,217.07726434,vLess-DILI-Concern,active
266,2585,carvedilol,COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12,406.189257312,vLess-DILI-Concern,active
267,40958,cefaclor,NC(C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(Cl)CS[C@H]12)c1ccccc1,367.039354608,vLess-DILI-Concern,active
268,2610,cefadroxil,CC1=C(C(=O)O)N2C(=O)C(NC(=O)C(N)c3ccc(O)cc3)C2SC1,363.088891644,vLess-DILI-Concern,active
269,656510,cefazolin,Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)C3SC2)s1,454.030013928,vLess-DILI-Concern,active
270,6915944,cefdinir,C=CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)/C(=N\O)c3csc(N)n3)[C@H]2SC1,395.035810516,vLess-DILI-Concern,active
271,5479537,cefepime,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(C[N+]3(C)CCCC3)CS[C@H]12)c1csc(N)n1,480.124959868,vLess-DILI-Concern,active
272,44185,cefoperazone,CCN1CCN(C(=O)NC(C(=O)N[C@@H]2C(=O)N3C(C(=O)O)=C(CSc4nnnn4C)CS[C@H]23)c2ccc(O)cc2)C(=O)C1=O,645.142400824,vLess-DILI-Concern,active
273,456256,cefotaxime,CON=C(C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(C)=O)CS[C@H]12)c1csc(N)n1,455.056939884,vLess-DILI-Concern,active
274,5281006,cefprozil,C/C=C/C1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccc(O)cc3)[C@H]2SC1,389.104541708,vLess-DILI-Concern,active
275,5481173,ceftazidime,CC(C)(O/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(C[n+]3ccccc3)CS[C@H]12)c1csc(N)n1)C(=O)O,546.099139044,vLess-DILI-Concern,active
276,5361919,ceftriaxone,CO/N=C(/C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(CSc3nc(=O)c(=O)[nH]n3C)CS[C@H]12)c1csc(N)n1,554.046057916,vLess-DILI-Concern,active
277,5361202,cefuroxime,CO/N=C(/C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,424.068884472,vLess-DILI-Concern,active
278,27447,cephalexin,CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccccc3)[C@H]2SC1,347.093977024,vLess-DILI-Concern,active
279,2678,cetirizine,O=C(O)COCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1,388.15537034,vLess-DILI-Concern,active
280,2712,chlordiazepoxide,CN=C1CN(O)C(c2ccccc2)=c2cc(Cl)ccc2=N1,299.082539748,vLess-DILI-Concern,active
281,2719,chloroquine,CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12,319.181525512,vLess-DILI-Concern,active
282,2720,chlorothiazide,NS(=O)(=O)c1cc2c(cc1Cl)NC=NS2(=O)=O,294.948825352,vLess-DILI-Concern,active
283,2726,chlorpromazine,CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21,318.095747288,vLess-DILI-Concern,active
284,2727,chlorpropamide,CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1,276.033540956,vLess-DILI-Concern,active
285,2756,cimetidine,CN=C(NC#N)NCCSCc1nc[nH]c1C,252.115715512,vLess-DILI-Concern,active
286,2771,citalopram,CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21,324.163791512,vLess-DILI-Concern,active
287,2802,clonazepam,O=C1CN=C(c2ccccc2Cl)c2cc([N+](=O)[O-])ccc2N1,315.04106886,vLess-DILI-Concern,active
288,60606,clopidogrel,COC(=O)[C@H](c1ccccc1Cl)N1CCc2sccc2C1,321.059027432,vLess-DILI-Concern,active
289,27686,cromoglicate,O=C(O)c1cc(=O)c2cc(OCC(O)COc3cccc4oc(C(=O)O)cc(=O)c34)ccc2o1,468.069261332,vLess-DILI-Concern,active
290,2895,cyclobenzaprine,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,275.167399672,vLess-DILI-Concern,active
291,2907,cyclophosphamide,O=P1(N(CCCl)CCCl)NCCCO1,260.02481971,vLess-DILI-Concern,active
292,2913,cyproheptadine,CN1CCC(=C2c3ccccc3C=Cc3ccccc32)CC1,287.167399672,vLess-DILI-Concern,active
293,347910371,dalteparin sodium,O=C(O)C1OC(OC2C(COS(=O)(=O)O)OC(O)C(NS(=O)(=O)O)C2O)C(OS(=O)(=O)O)C(O)C1O,594.981905072,vLess-DILI-Concern,active
294,3062316,dasatinib,Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1,487.155721752,vLess-DILI-Concern,active
295,124087,desloratadine,Clc1ccc2c(c1)CCc1cccnc1C2=C1CCNCC1,310.123676288,vLess-DILI-Concern,active
296,125017,desvenlafaxine,CN(C)CC(c1ccc(O)cc1)C1(O)CCCCC1,263.18852904,vLess-DILI-Concern,active
297,154101,dexmethylphenidate,COC(=O)[C@H](c1ccccc1)[C@H]1CCCCN1,233.141578848,vLess-DILI-Concern,active
298,3114,disopyramide,CC(C)N(CCC(C(N)=O)(c1ccccc1)c1ccccn1)C(C)C,339.231062548,vLess-DILI-Concern,active
299,3152,donepezil,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,379.214743788,vLess-DILI-Concern,active
300,667477,doxepin,CN(C)CC/C=C1\c2ccccc2COc2ccccc21,279.162314292,vLess-DILI-Concern,active
301,31703,doxorubicin,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,543.174060748,vLess-DILI-Concern,active
302,5281011,doxycycline,C[C@H]1c2cccc(O)c2C(=O)C2C(=O)[C@]3(O)C(=O)C(C(N)=O)C(=O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21,444.153265728,vLess-DILI-Concern,active
303,5362032,enalapril,CCOC(=O)[C@@H](CCc1ccccc1)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)O,376.199821996,vLess-DILI-Concern,active
304,25244225,enoxaparin,O=C(O)C1O[C@@H](OC2[C@@H](COS(=O)(=O)O)OC(O)C(NS(=O)(=O)O)[C@H]2O)C(OS(=O)(=O)O)[C@@H](O)C1O,594.981905072,vLess-DILI-Concern,active
305,146570,escitalopram,CN(C)CCC[C@@]1(c2ccc(F)cc2)OCc2cc(C#N)ccc21,324.163791512,vLess-DILI-Concern,active
306,9579578,esomeprazole Sodium,COc1ccc2nc([S@+]([O-])Cc3ncc(C)c(OC)c3C)[nH]c2c1,345.114712468,vLess-DILI-Concern,active
307,5757,estradiol,C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CC[C@@H]2O,272.177630008,vLess-DILI-Concern,active
308,36462,etoposide,COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O,588.184291084,vLess-DILI-Concern,active
309,3325,famotidine,NC(N)=Nc1nc(CSCCC(N)=NS(N)(=O)=O)cs1,337.04493572,vLess-DILI-Concern,active
310,3333,felodipine,CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc(Cl)c1Cl,383.069113448,vLess-DILI-Concern,active
311,3356,flecainide,O=C(NCC1CCCCN1)c1cc(OCC(F)(F)F)ccc1OCC(F)(F)F,414.13781182,vLess-DILI-Concern,active
312,3386,fluoxetine,CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1,309.134048856,vLess-DILI-Concern,active
313,3393,flurazepam,CCN(CC)CCN1C(=O)CN=C(c2ccccc2F)c2cc(Cl)ccc21,387.151368256,vLess-DILI-Concern,active
314,446987,fosfomycin,C[C@@H]1O[C@@H]1P(=O)(O)O,138.008195334,vLess-DILI-Concern,active
315,55891,fosinopril,CCC(=O)OC(OP(=O)(CCCCc1ccccc1)CC(=O)N1C[C@H](C2CCCCC2)C[C@H]1C(=O)O)C(C)C,563.301189442,vLess-DILI-Concern,active
316,3488,glibenclamide,COc1ccc(Cl)cc1C(=O)NCCc1ccc(S(=O)(=O)NC(=O)NC2CCCCC2)cc1,493.143819676,vLess-DILI-Concern,active
317,3476,glimepiride,CCC1=C(C)CN(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)NC3CCC(C)CC3)cc2)C1=O,490.224991188,vLess-DILI-Concern,active
318,3478,glipizide,Cc1cnc(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)NC3CCCCC3)cc2)cn1,445.178375344,vLess-DILI-Concern,active
319,3559,haloperidol,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,375.140134876,vLess-DILI-Concern,active
320,3637,hydralazine,NNc1nncc2ccccc12,160.074896256,vLess-DILI-Concern,active
321,3639,hydrochlorothiazide,NS(=O)(=O)c1cc2c(cc1Cl)NCNS2(=O)=O,296.964475416,vLess-DILI-Concern,active
322,3652,hydroxychloroquine,CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12,335.176440132,vLess-DILI-Concern,active
323,3690,ifosfamide,O=P1(NCCCl)OCCCN1CCCl,260.02481971,vLess-DILI-Concern,active
324,3696,imipramine,CN(C)CCCN1c2ccccc2CCc2ccccc21,280.193948768,vLess-DILI-Concern,active
325,3749,irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1,428.232459516,vLess-DILI-Concern,active
326,60838,irinotecan,CCc1c2c(nc3ccc(OC(=O)N4CCC(N5CCCCC5)CC4)cc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC,586.279134936,vLess-DILI-Concern,active
327,3784,isradipine,COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1c1cccc2nonc12,371.148120772,vLess-DILI-Concern,active
328,3883,lansoprazole,Cc1c(OCC(F)(F)F)ccnc1C[S+]([O-])c1nc2ccccc2[nH]1,369.075882348,vLess-DILI-Concern,active
329,441341,levetiracetam,CC[C@H](C(N)=O)N1CCCC1=O,170.105527688,vLess-DILI-Concern,active
330,1549000,levocetirizine dihydrochloride,O=C(O)COCCN1CCN([C@H](c2ccccc2)c2ccc(Cl)cc2)CC1,388.15537034,vLess-DILI-Concern,active
331,5819,levothyroxine,N[C@@H](Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1)C(=O)O,776.686699832,vLess-DILI-Concern,active
332,441401,linezolid,CC(=O)NC[C@H]1CN(c2ccc(N3CCOCC3)c(F)c2)C(=O)O1,337.14378434,vLess-DILI-Concern,active
333,5362119,lisinopril,NCCCC[C@H](N[C@@H](CCc1ccccc1)C(=O)O)C(=O)N1CCC[C@H]1C(=O)O,405.226371092,vLess-DILI-Concern,active
334,3956,loracarbef,NC(C(=O)NC1C(=O)N2C(C(=O)O)=C(Cl)CCC12)c1ccccc1,349.082933672,vLess-DILI-Concern,active
335,3961,losartan,CCCCc1nc(Cl)c(CO)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1,422.162187036,vLess-DILI-Concern,active
336,4046,mefloquine,OC(c1cc(C(F)(F)F)nc2c(C(F)(F)F)cccc12)C1CCCCN1,378.116682452,vLess-DILI-Concern,active
337,4053,melphalan,NC(Cc1ccc(N(CCCl)CCCl)cc1)C(=O)O,304.074533176,vLess-DILI-Concern,active
338,4054,memantine,CC12CC3CC(C)(C1)CC(N)(C3)C2,179.167399672,vLess-DILI-Concern,active
339,4075,mesalazine,Nc1ccc(O)c(C(=O)O)c1,153.042593084,vLess-DILI-Concern,active
340,15459,metaxalone,Cc1cc(C)cc(OCC2CNC(=O)O2)c1,221.10519334,vLess-DILI-Concern,active
341,4100,methazolamide,CC(=O)N=c1sc(S(N)(=O)=O)nn1C,236.003782116,vLess-DILI-Concern,active
342,4158,methylphenidate,COC(=O)C(c1ccccc1)C1CCCCN1,233.141578848,vLess-DILI-Concern,active
343,6741,methylprednisolone,C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@H]2[C@@]2(C)C=CC(=O)C=C12,374.20932406,vLess-DILI-Concern,active
344,4168,metoclopramide,CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC,299.140054624,vLess-DILI-Concern,active
345,4171,metoprolol,COCCc1ccc(OCC(O)CNC(C)C)cc1,267.18344366,vLess-DILI-Concern,active
346,5281040,montelukast,CC(C)(O)c1ccccc1CC[C@@H](SCC1(CC(=O)O)CC1)c1cccc(/C=C/c2ccc3ccc(Cl)cc3n2)c1,585.210442692,vLess-DILI-Concern,active
347,152946,moxifloxacin,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,401.175084468,vLess-DILI-Concern,active
348,5281078,mycophenolate mofetil,COc1c(C)c2c(c(O)c1C/C=C(\C)CCC(=O)OCCN1CCOCC1)C(=O)OC2,433.210052332,vLess-DILI-Concern,active
349,3011155,nelarabine,COc1nc(N)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,297.10731858,vLess-DILI-Concern,active
350,64143,nelfinavir,Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C,567.31307792,vLess-DILI-Concern,active
351,3033637,nizatidine,CN/C(=C\[N+](=O)[O-])NCCSCc1csc(CN(C)C)n1,331.113666912,vLess-DILI-Concern,active
352,4585,olanzapine,Cc1cc2c(s1)=Nc1ccccc1NC=2N1CCN(C)CC1,312.14086764,vLess-DILI-Concern,active
353,6003770,olsalazine,O=C(O)C1=C/C(=N\Nc2ccc(O)c(C(=O)O)c2)C=CC1=O,302.05388604,vLess-DILI-Concern,active
354,4594,omeprazole,COc1ccc2nc([S+]([O-])Cc3ncc(C)c(OC)c3C)[nH]c2c1,345.114712468,vLess-DILI-Concern,active
355,4595,ondansetron,Cc1nccn1CC1CCc2c(c3ccccc3n2C)C1=O,293.152812228,vLess-DILI-Concern,active
356,36314,paclitaxel,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,853.330955312,vLess-DILI-Concern,active
357,4679,pantoprazole,COc1ccnc(C[S+]([O-])c2nc3ccc(OC(F)F)cc3[nH]2)c1OC,383.0751334,vLess-DILI-Concern,active
358,43815,paroxetine,Fc1ccc([C@@H]2CCNC[C@H]2COc2ccc3c(c2)OCO3)cc1,329.14272172,vLess-DILI-Concern,active
359,436058,pegaspargase,C=C(CN(C)C)C(=O)c1ccc(C)cc1C,217.146664228,vLess-DILI-Concern,active
360,5904,penicillin g,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,334.098728056,vLess-DILI-Concern,active
361,3675,phenelzine,NNCCc1ccccc1,136.100048384,vLess-DILI-Concern,active
362,5755,prednisolone,C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO,360.193673996,vLess-DILI-Concern,active
363,5865,prednisone,C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO,358.178023932,vLess-DILI-Concern,active
364,4913,procainamide,CCN(CC)CCNC(=O)c1ccc(N)cc1,235.168462292,vLess-DILI-Concern,active
365,4917,prochlorperazine,CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,373.137946448,vLess-DILI-Concern,active
366,5994,progesterone,CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,314.2245802,vLess-DILI-Concern,active
367,4927,promethazine,CC(CN1c2ccccc2Sc2ccccc21)N(C)C,284.13471964,vLess-DILI-Concern,active
368,4932,propafenone,CCCNCC(O)COc1ccccc1C(=O)CCc1ccccc1,341.199093724,vLess-DILI-Concern,active
369,4943,propofol,CC(C)c1cccc(C(C)C)c1O,178.135765196,vLess-DILI-Concern,active
370,15330,propoxyphene,CCC(=O)OC(Cc1ccccc1)(c1ccccc1)C(C)CN(C)C,339.219829168,vLess-DILI-Concern,active
371,54892,quinapril,CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1Cc2ccccc2C[C@H]1C(=O)O,438.21547206,vLess-DILI-Concern,active
372,441074,quinidine,C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@@H](O)c1ccnc2ccc(OC)cc12,324.183778008,vLess-DILI-Concern,active
373,5029,rabeprazole,COCCCOc1ccnc(C[S+]([O-])c2nc3ccccc3[nH]2)c1C,359.130362532,vLess-DILI-Concern,active
374,5362129,ramipril,CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1[C@H](C(=O)O)C[C@@H]2CCC[C@@H]21,416.231122124,vLess-DILI-Concern,active
375,3001055,ranitidine,CN/C(=C\[N+](=O)[O-])NCCSCc1ccc(CN(C)C)o1,314.141261564,vLess-DILI-Concern,active
376,60815,remifentanil,CCC(=O)N(c1ccccc1)C1(C(=O)OC)CCN(CCC(=O)OC)CC1,376.199821996,vLess-DILI-Concern,active
377,65981,repaglinide,CCOc1cc(CC(=O)N[C@@H](CC(C)C)c2ccccc2N2CCCCC2)ccc1C(=O)O,452.267507632,vLess-DILI-Concern,active
378,6323490,rifabutin,CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(c3C2=O)C2=NC3(CCN(CC(C)C)CC3)NC2=C(NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C4=O,846.441508804,vLess-DILI-Concern,active
379,5073,risperidone,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2,410.211804324,vLess-DILI-Concern,active
380,77991,rivastigmine,CCN(C)C(=O)Oc1cccc([C@H](C)N(C)C)c1,250.168127944,vLess-DILI-Concern,active
381,5095,ropinirole,CCCN(CCC)CCc1cccc2c1CC(=O)N2,260.188863388,vLess-DILI-Concern,active
382,68617,sertraline,CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21,305.073804904,vLess-DILI-Concern,active
383,5210,sibutramine,CC(C)CC(N(C)C)C1(c2ccc(Cl)cc2)CCC1,279.175377512,vLess-DILI-Concern,active
384,5212,sildenafil,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,474.20492444,vLess-DILI-Concern,active
385,6436030,sirolimus,CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)CC2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,913.555141588,vLess-DILI-Concern,active
386,4369359,sitagliptin,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F,407.11807942,vLess-DILI-Concern,active
387,5833,spironolactone,CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@@]34CCC(=O)O4)[C@@H]21,416.202130504,vLess-DILI-Concern,active
388,5215,sulfadiazine,Nc1ccc(S(=O)(=O)Nc2ncccn2)cc1,250.05244656,vLess-DILI-Concern,active
389,439492,tacrolimus,C=CC[C@@H]1C=C(C)C[C@H](C)C[C@H](OC)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](C(C)=C[C@@H]3CC[C@@H](O)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC,803.481976648,vLess-DILI-Concern,active
390,65999,telmisartan,CCCc1nc2c(C)cc(-c3nc4ccccc4n3C)cc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1,514.2368762,vLess-DILI-Concern,active
391,5394,temozolomide,Cn1nnc2c(C(N)=O)ncn2c1=O,194.055223432,vLess-DILI-Concern,active
392,5403,terbutaline,CC(C)(C)NCC(O)c1cc(O)cc(O)c1,225.136493468,vLess-DILI-Concern,active
393,5426,thalidomide,O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1,258.0640568,vLess-DILI-Concern,active
394,5452,thioridazine,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2,370.153740832,vLess-DILI-Concern,active
395,5479,tinidazole,CCS(=O)(=O)CCn1c([N+](=O)[O-])cnc1C,247.062676896,vLess-DILI-Concern,active
396,5503,tolazamide,Cc1ccc(S(=O)(=O)NC(=O)NN2CCCCCC2)cc1,311.130362532,vLess-DILI-Concern,active
397,5509,tolmetin,Cc1ccc(C(=O)c2ccc(CC(=O)O)n2C)cc1,257.10519334,vLess-DILI-Concern,active
398,5284627,topiramate,CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1,339.098787632,vLess-DILI-Concern,active
399,5484727,trandolapril,CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1[C@H](C(=O)O)C[C@H]2CCCC[C@@H]21,430.246772188,vLess-DILI-Concern,active
400,441233,tranylcypromine,N[C@@H]1CC1c1ccccc1,133.089149352,vLess-DILI-Concern,active
401,5533,trazodone,O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12,371.151288004,vLess-DILI-Concern,active
402,5546,triamterene,Nc1nc(N)c2nc(-c3ccccc3)c(N)nc2n1,253.107593352,vLess-DILI-Concern,active
403,5578,trimethoprim,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,290.137890436,vLess-DILI-Concern,active
404,60773,valaciclovir,CC(C)[C@H](N)C(=O)OCCOCn1cnc2c(=O)[nH]c(N)nc21,324.15460312,vLess-DILI-Concern,active
405,60846,valsartan,CCCCC(=O)N(Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1)[C@H](C(=O)O)C(C)C,435.227039788,vLess-DILI-Concern,active
406,5310966,varenicline,c1cnc2cc3c(cc2n1)[C@H]1CNC[C@@H]3C1,211.110947416,vLess-DILI-Concern,active
407,5656,venlafaxine,COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1,277.204179104,vLess-DILI-Concern,active
408,5978,vincristine,CC[C@]1(O)C[C@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C=O)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1,824.399643992,vLess-DILI-Concern,active
409,6691,warfarin,CC(=O)CC(c1ccccc1)c1c(O)oc2ccccc2c1=O,308.104858992,vLess-DILI-Concern,active
410,60854,ziprasidone,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,412.112459972,vLess-DILI-Concern,active
411,5734,zonisamide,NS(=O)(=O)Cc1noc2ccccc12,212.025563116,vLess-DILI-Concern,active
412,71771,aceclofenac,O=C(O)COC(=O)Cc1ccccc1Nc1c(Cl)cccc1Cl,353.022163256,vLess-DILI-Concern,active
413,2088,alendronate,NCCCC(O)(P(=O)(O)O)P(=O)(O)O,249.016725016,vLess-DILI-Concern,active
414,5493444,aliskiren,COCCCOc1cc(C[C@@H](C[C@H](N)[C@@H](O)C[C@H](C(=O)NCC(C)(C)C(N)=O)C(C)C)C(C)C)ccc1OC,551.393436416,vLess-DILI-Concern,active
415,3007,amphetamine,CC(N)Cc1ccccc1,135.104799416,vLess-DILI-Concern,active
416,2244,aspirin,CC(=O)Oc1ccccc1C(=O)O,180.042258736,vLess-DILI-Concern,active
417,7699,benzonatate,CCCCNc1ccc(C(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOC)cc1,603.361861516,vLess-DILI-Concern,active
418,2710,chlorcyclizine,CN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1,300.139326352,vLess-DILI-Concern,active
419,2973,deferoxamine,CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN,560.353362496,vLess-DILI-Concern,active
420,5281081,entacapone,CCN(CC)C(=O)/C(C#N)=C/c1cc(O)c(O)c([N+](=O)[O-])c1,305.10117058,vLess-DILI-Concern,active
421,57363,finasteride,CC(C)(C)NC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4NC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C,372.277678392,vLess-DILI-Concern,active
422,3385,fluorouracil,O=c1[nH]cc(F)c(=O)[nH]1,130.017855556,vLess-DILI-Concern,active
423,3038497,fospropofol,CC(C)c1cccc(C(C)C)c1OCOP(=O)([O-])[O-],286.0981074978,vLess-DILI-Concern,active
424,3821,ketamine,CNC1(c2ccccc2Cl)CCCCC1=O,237.092041812,vLess-DILI-Concern,active
425,4091,metformin,CN(C)C(=N)N=C(N)N,129.101445352,vLess-DILI-Concern,active
426,4173,metronidazole,Cc1ncc([N+](=O)[O-])n1CCO,171.064391148,vLess-DILI-Concern,active
427,5746,mitomycin,CO[C@@]12[C@H](COC(N)=O)C3=C(C(=O)C(C)=C(N)C3=O)N1C[C@@H]1N[C@@H]12,334.127719676,vLess-DILI-Concern,active
428,4771,phentermine,CC(C)(N)Cc1ccccc1,149.12044948,vLess-DILI-Concern,active
429,6918456,prasugrel hydrochloride,CC(=O)Oc1cc2c(s1)CCN(C(C(=O)C1CC1)c1ccccc1F)C2,373.11479272,vLess-DILI-Concern,active
430,5486971,pregabalin,CC(C)C[C@H](CN)CC(=O)O,159.125928784,vLess-DILI-Concern,active
431,5328,sulfamethizole,Cc1nnc(NS(=O)(=O)c2ccc(N)cc2)s1,270.02451756,vLess-DILI-Concern,active
432,129211,tamsulosin,CCOc1ccccc1OCCN[C@H](C)Cc1ccc(OC)c(S(N)(=O)=O)c1,408.171892996,vLess-DILI-Concern,active
433,68740,zoledronate,O=P(O)(O)C(O)(Cn1ccnc1)P(=O)(O)O,271.99632392,vLess-DILI-Concern,active
434,187,acetylcholine chloride,CC(=O)OCC[N+](C)(C)C,146.1175551721,vNo-DILI-Concern,inactive
435,12035,acetylcysteine,CC(=O)N[C@@H](CS)C(=O)O,163.030314148,vNo-DILI-Concern,inactive
436,60961,adenosine,Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,267.096753896,vNo-DILI-Concern,inactive
437,51263,alfentanil,CCC(=O)N(c1ccccc1)C1(COC)CCN(CCn2nnn(CC)c2=O)CC1,416.253588884,vNo-DILI-Concern,inactive
438,123606,almotriptan,CN(C)CCc1c[nH]c2ccc(CS(=O)(=O)N3CCCC3)cc12,335.16674804,vNo-DILI-Concern,inactive
439,5488548,alvimopan,C[C@H]1CN(C[C@H](Cc2ccccc2)C(=O)NCC(=O)O)CC[C@@]1(C)c1cccc(O)c1,424.236207504,vNo-DILI-Concern,inactive
440,2131,ambenonium,CC[N+](CC)(CCNC(=O)C(=O)NCC[N+](CC)(CC)Cc1ccccc1Cl)Cc1ccccc1Cl,536.2673847842,vNo-DILI-Concern,inactive
441,2141,amifostine,NCCCNCCSP(=O)(O)O,214.05409997,vNo-DILI-Concern,inactive
442,37768,amikacin,NCC[C@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](N)[C@H]1O,585.285736436,vNo-DILI-Concern,inactive
443,564,aminocaproic acid,NCCCCCC(=O)O,131.094628656,vNo-DILI-Concern,inactive
444,2148,aminohippurate,Nc1ccc(C(=O)NCC(=O)O)cc1,194.06914218,vNo-DILI-Concern,inactive
445,6005,apomorphine,CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3,267.125928784,vNo-DILI-Concern,inactive
446,152951,argatroban,C[C@H]1CNc2c(cccc2S(=O)(=O)N[C@@H](CCCN=C(N)N)C(=O)N2CC[C@@H](C)C[C@@H]2C(=O)O)C1,508.246789252,vNo-DILI-Concern,inactive
447,47319,atracurium,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC,928.5074285842,vNo-DILI-Concern,inactive
448,174174,atropine,CN1[C@H]2CC[C@@H]1CC(OC(=O)C(CO)c1ccccc1)C2,289.167793596,vNo-DILI-Concern,inactive
449,65628,bendamustine,Cn1c(CCCC(=O)O)nc2cc(N(CCCl)CCCl)ccc21,357.101082272,vNo-DILI-Concern,inactive
450,2341,benzphetamine,CC(Cc1ccccc1)N(C)Cc1ccccc1,239.167399672,vNo-DILI-Concern,inactive
451,6832,benztropine,CN1[C@@H]2CC[C@@H]1CC(OC(c1ccccc1)c1ccccc1)C2,307.19361442,vNo-DILI-Concern,inactive
452,119212,benzylpenicilloyl polylysine,CC1(C)SC(C(NC(=O)Cc2ccccc2)C(=O)NCCCCCC(=O)O)NC1C(=O)O,465.193356712,vNo-DILI-Concern,inactive
453,247,betaine,C[N+](C)(C)CC(=O)[O-],117.078978592,vNo-DILI-Concern,inactive
454,2370,bethanechol,CC(C[N+](C)(C)C)OC(N)=O,161.1284542041,vNo-DILI-Concern,inactive
455,2381,biperiden,OC(CCN1CCCCC1)(c1ccccc1)C1CC2C=CC1C2,311.224914548,vNo-DILI-Concern,inactive
456,2391,bisacodyl,CC(=O)Oc1ccc(C(c2ccc(OC(C)=O)cc2)c2ccccn2)cc1,361.131408088,vNo-DILI-Concern,inactive
457,6834,brompheniramine,CN(C)CCC(c1ccc(Br)cc1)c1ccccn1,318.073160708,vNo-DILI-Concern,inactive
458,63006,budesonide,CCC[C@H]1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1,430.235538808,vNo-DILI-Concern,inactive
459,5361092,butorphanol,Oc1ccc2c(c1)[C@@]13CCCC[C@@]1(O)[C@@H](C2)N(CC1CCC1)CC3,327.219829168,vNo-DILI-Concern,inactive
460,54746,cabergoline,C=CCN1C[C@H](C(=O)N(CCCN(C)C)C(=O)NCC)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21,451.294725424,vNo-DILI-Concern,inactive
461,2519,caffeine,Cn1c(=O)c2c(ncn2C)n(C)c1=O,194.08037556,vNo-DILI-Concern,inactive
462,134070,calcitriol,C=C1C(=CC=C2CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@H](C)CCCC(C)(C)O)C[C@@H](O)C[C@@H]1O,416.329045268,vNo-DILI-Concern,inactive
463,2564,carbinoxamine,CN(C)CCOC(c1ccc(Cl)cc1)c1ccccn1,290.118590908,vNo-DILI-Concern,inactive
464,5284525,carboprost tromethamine,CCCCC[C@](C)(O)/C=C/[C@H]1[C@H](O)C[C@H](O)[C@@H]1C/C=C/CCCC(=O)O,368.256274252,vNo-DILI-Concern,inactive
465,2576,carisoprodol,CCCC(C)(COC(N)=O)COC(=O)NC(C)C,260.173607248,vNo-DILI-Concern,inactive
466,298,chloramphenicol,O=C(NC(CO)C(O)c1ccc([N+](=O)[O-])cc1)C(Cl)Cl,322.012326844,vNo-DILI-Concern,inactive
467,2725,chlorpheniramine,CN(C)CCC(c1ccc(Cl)cc1)c1ccccn1,274.123676288,vNo-DILI-Concern,inactive
468,156419,cinacalcet,C[C@@H](NCCCc1cccc(C(F)(F)F)c1)c1cccc2ccccc12,357.170434364,vNo-DILI-Concern,inactive
469,62886,cisatracurium besylate,COc1ccc(C[C@@H]2c3cc(OC)c(OC)cc3CC[N@+]2(C)CCC(=O)OCCCCCOC(=O)CC[N@@+]2(C)CCc3cc(OC)c(OC)cc3[C@H]2Cc2ccc(OC)c(OC)c2)cc1OC,928.5074285842,vNo-DILI-Concern,inactive
470,26987,clemastine,CN1CCC[C@@H]1CCO[C@](C)(c1ccccc1)c1ccc(Cl)cc1,343.170292132,vNo-DILI-Concern,inactive
471,153994,clevidipine,CCCC(=O)OCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc(Cl)c1Cl,455.090242816,vNo-DILI-Concern,inactive
472,5284371,codeine,COc1ccc2c3c1O[C@H]1[C@@H](O)C=C[C@H]4[C@@H](C2)N(C)CC[C@]314,299.152143532,vNo-DILI-Concern,inactive
473,151171,conivaptan,Cc1nc2c([nH]1)CCN(C(=O)c1ccc(NC(=O)c3ccccc3-c3ccccc3)cc1)c1ccccc1-2,498.205576072,vNo-DILI-Concern,inactive
474,5745,cortisone acetate,CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3C(=O)C[C@@]21C,402.20423868,vNo-DILI-Concern,inactive
475,444031,darifenacin,NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(CCc2ccc3c(c2)CCO3)C1,426.2307282,vNo-DILI-Concern,inactive
476,30323,daunorubicin,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(C)=O)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,527.179146128,vNo-DILI-Concern,inactive
477,4678,dexpanthenol,CC(C)(CO)C(O)C(=O)NCCCO,205.131408088,vNo-DILI-Concern,inactive
478,5360696,dextromethorphan,COc1ccc2c(c1)[C@]13CCCC[C@@H]1[C@H](C2)N(C)CC3,271.19361442,vNo-DILI-Concern,inactive
479,5793,dextrose,OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O,180.063388104,vNo-DILI-Concern,inactive
480,2140,diatrizoate,CC(=O)Nc1c(I)c(NC(C)=O)c(I)c(C(=O)O)c1I,613.769650768,vNo-DILI-Concern,inactive
481,3038,dichlorphenamide,NS(=O)(=O)c1cc(Cl)c(Cl)c(S(N)(=O)=O)c1,303.914604032,vNo-DILI-Concern,inactive
482,3042,dicyclomine,CCN(CC)CCOC(=O)C1(C2CCCCC2)CCCCC1,309.26677936,vNo-DILI-Concern,inactive
483,7029,diethylpropion,CCN(CC)C(C)C(=O)c1ccccc1,205.146664228,vNo-DILI-Concern,inactive
484,30322,digoxin,C[C@H]1O[C@@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@]5(C)[C@H]6C[C@@H](O)[C@]7(C)C(C8=CC(=O)OC8)CC[C@]7(O)[C@@H]6CC[C@@H]5C4)O[C@@H]3C)O[C@@H]2C)C[C@H](O)[C@@H]1O,780.429606728,vNo-DILI-Concern,inactive
485,10531,dihydroergotamine,CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21,583.279469284,vNo-DILI-Concern,inactive
486,3080,dimercaprol,OCC(S)CS,124.001656876,vNo-DILI-Concern,inactive
487,3100,diphenhydramine,CN(C)CCOC(c1ccccc1)c1ccccc1,255.162314292,vNo-DILI-Concern,inactive
488,13505,diphenoxylate,CCOC(=O)C1(c2ccccc2)CCN(CCC(C#N)(c2ccccc2)c2ccccc2)CC1,452.246378264,vNo-DILI-Concern,inactive
489,36811,dobutamine,CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1,301.167793596,vNo-DILI-Concern,inactive
490,71329,dofetilide,CN(CCOc1ccc(NS(C)(=O)=O)cc1)CCc1ccc(NS(C)(=O)=O)cc1,441.139212964,vNo-DILI-Concern,inactive
491,681,dopamine,NCCc1ccc(O)c(O)c1,153.078978592,vNo-DILI-Concern,inactive
492,3156,doxapram,CCN1CC(CCN2CCOCC2)C(c2ccccc2)(c2ccccc2)C1=O,378.2307282,vNo-DILI-Concern,inactive
493,3162,doxylamine,CN(C)CCOC(C)(c1ccccc1)c1ccccn1,270.173213324,vNo-DILI-Concern,inactive
494,3168,droperidol,O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1,379.169605164,vNo-DILI-Concern,inactive
495,152945,dutasteride,C[C@]12CCC3[C@@H](CC[C@H]4NC(=O)C=C[C@]34C)[C@@H]1CC[C@@H]2C(=O)Nc1cc(C(F)(F)F)ccc1C(F)(F)F,528.22114752,vNo-DILI-Concern,inactive
496,3182,dyphylline,Cn1c(=O)c2c(ncn2CC(O)CO)n(C)c1=O,254.101504928,vNo-DILI-Concern,inactive
497,3202,edrophonium,CC[N+](C)(C)c1cccc(O)c1,166.1226405521,vNo-DILI-Concern,inactive
498,9294,ephedrine,CN[C@@H](C)[C@H](O)c1ccccc1,165.1153641,vNo-DILI-Concern,inactive
499,5816,epinephrine,CNC[C@H](O)c1ccc(O)c(O)c1,183.089543276,vNo-DILI-Concern,inactive
500,127893,epoetin alfa,O=C(CNC(=O)c1ccccc1)CC(Cc1ccccc1)C(=O)O,325.131408088,vNo-DILI-Concern,inactive
501,123610,eptifibatide,NC(=O)C1CSSCCC(=O)NC(CCCCN=C(N)N)C(=O)NCC(=O)NC(CC(=O)O)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)N2CCCC2C(=O)N1,831.315614148,vNo-DILI-Concern,inactive
502,5280793,ergocalciferol,C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)/C=C/[C@H](C)C(C)C,396.339216028,vNo-DILI-Concern,inactive
503,59768,esmolol,COC(=O)CCc1ccc(OCC(O)CNC(C)C)cc1,295.17835828,vNo-DILI-Concern,inactive
504,3261,estazolam,Clc1ccc2c(c1)C(c1ccccc1)=NCc1nncn1-2,294.067224032,vNo-DILI-Concern,inactive
505,3305,etidronic acid,CC(O)(P(=O)(O)O)P(=O)(O)O,205.974525856,vNo-DILI-Concern,inactive
506,36339,etomidate,CCOC(=O)c1cncn1C(C)c1ccccc1,244.121177752,vNo-DILI-Concern,inactive
507,9552071,exametazime,C/C(=N\O)[C@@H](C)NCC(C)(C)CN[C@H](C)/C(C)=N/O,272.221226136,vNo-DILI-Concern,inactive
508,3341,fenoldopam,Oc1ccc(C2CNCCc3c2cc(O)c(O)c3Cl)cc1,305.081871052,vNo-DILI-Concern,inactive
509,9849808,fesoterodine,CC(C)C(=O)Oc1ccc(CO)cc1[C@H](CCN(C(C)C)C(C)C)c1ccccc1,411.277344044,vNo-DILI-Concern,inactive
510,3348,fexofenadine,CC(C)(C(=O)O)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1,501.287908728,vNo-DILI-Concern,inactive
511,3354,flavoxate,Cc1c(-c2ccccc2)oc2c(C(=O)OCCN3CCCCC3)cccc2c1=O,391.17835828,vNo-DILI-Concern,inactive
512,30751,fludarabine,Nc1nc(F)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@@H](O)[C@@H]1O,365.053662606,vNo-DILI-Concern,inactive
513,31378,fludrocortisone,C[C@]12C[C@H](O)[C@@]3(F)[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO,380.199902248,vNo-DILI-Concern,inactive
514,3373,flumazenil,CCOC(=O)c1ncn2c1CN(C)C(=O)c1cc(F)ccc1-2,303.101919528,vNo-DILI-Concern,inactive
515,16850,fluorescein,O=C1OC2(c3ccc(O)cc3Oc3cc(O)ccc32)c2ccccc21,332.068473484,vNo-DILI-Concern,inactive
516,6037,folic acid,Nc1nc2ncc(CNc3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)nc2c(=O)[nH]1,441.139681328,vNo-DILI-Concern,inactive
517,77992,frovatriptan,CN[C@@H]1CCc2[nH]c3ccc(C(N)=O)cc3c2C1,243.137162164,vNo-DILI-Concern,inactive
518,6918204,gadobenate dimeglumine,O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CCN(CC(=O)O)C(COCc1ccccc1)C(=O)O,513.195858812,vNo-DILI-Concern,inactive
519,158440,gadofosveset trisodium,O=C([O-])CN(CCN(CC(=O)O)C[C@H](COP(=O)(O)OC1CCC(c2ccccc2)(c2ccccc2)CC1)N(CC(=O)[O-])CC(=O)[O-])CC(=O)O,734.2342603617,vNo-DILI-Concern,inactive
520,60714,gadoteridol,CC(O)CN1CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC1,404.227099364,vNo-DILI-Concern,inactive
521,444013,gadoversetamide,COCCNC(=O)CN(CCN(CCN(CC(=O)O)CC(=O)NCCOC)CC(=O)O)CC(=O)O,507.254042384,vNo-DILI-Concern,inactive
522,23663870,gamma hydroxybutyric acid,O=C([O-])CCCO,103.0400676639,vNo-DILI-Concern,inactive
523,3494,glycopyrrolate,C[N+]1(C)CCC(OC(=O)C(O)(c2ccccc2)C2CCCC2)C1,318.2063701761,vNo-DILI-Concern,inactive
524,3516,guaifenesin,COc1ccccc1OCC(O)CO,198.089208928,vNo-DILI-Concern,inactive
525,3518,guanethidine,NC(N)=NCCN1CCCCCCC1,198.184446704,vNo-DILI-Concern,inactive
526,65513,histamine diphosphate,NCCc1cnc[nH]1,111.079647288,vNo-DILI-Concern,inactive
527,5754,hydrocortisone,C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO,362.20932406,vNo-DILI-Concern,inactive
528,3658,hydroxyzine,OCCOCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1,374.176105784,vNo-DILI-Concern,inactive
529,60852,ibandronate,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O,319.094975336,vNo-DILI-Concern,inactive
530,60753,ibutilide,CCCCCCCN(CC)CCCC(O)c1ccc(NS(C)(=O)=O)cc1,384.244664012,vNo-DILI-Concern,inactive
531,19190,indocyanine green,CC1(C)C(=CC=CC=CC=CC2=[N+](CCCCS(=O)(=O)[O-])c3ccc4ccccc4c3C2(C)C)N(CCCCS(=O)(=O)[O-])c2ccc3ccccc3c21,751.2881028039,vNo-DILI-Concern,inactive
532,3737,iothalamate sodium,CNC(=O)c1c(I)c(NC(C)=O)c(I)c(C(=O)O)c1I,613.769650768,vNo-DILI-Concern,inactive
533,3741,ioversol,O=C(NCC(O)CO)c1c(I)c(C(=O)NCC(O)CO)c(I)c(N(CCO)C(=O)CO)c1I,806.864673348,vNo-DILI-Concern,inactive
534,3779,isoproterenol,CC(C)NCC(O)c1ccc(O)c(O)c1,211.120843404,vNo-DILI-Concern,inactive
535,6883,isosorbide dinitrate,O=[N+]([O-])O[C@H]1CO[C@H]2[C@@H]1OC[C@H]2O[N+](=O)[O-],236.028065216,vNo-DILI-Concern,inactive
536,3783,isoxsuprine,CC(COc1ccccc1)NC(C)C(O)c1ccc(O)cc1,301.167793596,vNo-DILI-Concern,inactive
537,6032,kanamycin,NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,484.238057972,vNo-DILI-Concern,inactive
538,11333,lactulose,OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O,342.116211524,vNo-DILI-Concern,inactive
539,6322,l-arginine,NC(N)=NCCC[C@H](N)C(=O)O,174.111675688,vNo-DILI-Concern,inactive
540,10917,l-carnitine,C[N+](C)(C)C[C@H](O)CC(=O)[O-],161.10519334,vNo-DILI-Concern,inactive
541,54575,leucovorin,Nc1nc2c(c(=O)[nH]1)N(C=O)C(CNc1ccc(C(=O)N[C@H](CCC(=O)O)C(=O)O)cc1)CN2,473.165896076,vNo-DILI-Concern,inactive
542,15341110,levomefolate calcium,CN1c2c(nc(N)[nH]c2=O)NC[C@@H]1CNc1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1,459.18663152,vNo-DILI-Concern,inactive
543,13109,levonorgestrel,C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21CC,312.208930136,vNo-DILI-Concern,inactive
544,5359272,levorphanol,CN1CC[C@]23CCCC[C@H]2[C@H]1Cc1ccc(O)cc13,257.177964356,vNo-DILI-Concern,inactive
545,3676,lidocaine,CCN(CC)CC(=O)Nc1c(C)cccc1C,234.173213324,vNo-DILI-Concern,inactive
546,5920,liothyronine,N[C@@H](Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1)C(=O)O,650.790051864,vNo-DILI-Concern,inactive
547,6137,l-methionine,CSCC[C@H](N)C(=O)O,149.051049592,vNo-DILI-Concern,inactive
548,3955,loperamide,CN(C)C(=O)C(CCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1,476.223055976,vNo-DILI-Concern,inactive
549,3957,loratadine,CCOC(=O)N1CCC(=C2c3ccc(Cl)cc3CCc3cccnc32)CC1,382.144805656,vNo-DILI-Concern,inactive
550,656719,lubiprostone,CCCCC(F)(F)[C@@]1(O)CC[C@@H]2[C@H](CCCCCCC(=O)O)C(=O)C[C@H]2O1,390.221780564,vNo-DILI-Concern,inactive
551,453,mannitol,OCC(O)C(O)C(O)C(O)CO,182.079038168,vNo-DILI-Concern,inactive
552,4032,mecamylamine,CNC1(C)C2CCC(C2)C1(C)C,167.167399672,vNo-DILI-Concern,inactive
553,4034,meclizine,Cc1cccc(CN2CCN(C(c3ccccc3)c3ccc(Cl)cc3)CC2)c1,390.186276544,vNo-DILI-Concern,inactive
554,4057,mepenzolate,C[N+]1(C)CCCC(OC(=O)C(O)(c2ccccc2)c2ccccc2)C1,340.1907201121,vNo-DILI-Concern,inactive
555,4058,meperidine,CCOC(=O)C1(c2ccccc2)CCN(C)CC1,247.157228912,vNo-DILI-Concern,inactive
556,4062,mepivacaine,Cc1cccc(C)c1NC(=O)C1CCCCN1C,246.173213324,vNo-DILI-Concern,inactive
557,4064,meprobamate,CCCC(C)(COC(N)=O)COC(N)=O,218.126657056,vNo-DILI-Concern,inactive
558,10836,methamphetamine,CN[C@@H](C)Cc1ccccc1,149.12044948,vNo-DILI-Concern,inactive
559,6476,methsuximide,CN1C(=O)CC(C)(c2ccccc2)C1=O,203.094628656,vNo-DILI-Concern,inactive
560,8226,methylergonovine,CC[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1,339.19467704,vNo-DILI-Concern,inactive
561,5361917,methylnaltrexone bromide,C[N+]1(CC2CC2)CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5,356.1856347321,vNo-DILI-Concern,inactive
562,4120,methylscopolamine bromide,C[N+]1(C)C2CC(OC(=O)C(CO)c3ccccc3)CC1C1OC12,318.1699846681,vNo-DILI-Concern,inactive
563,9681,methysergide,CC[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4c3c(cn4C)C[C@H]2N(C)C1,353.210327104,vNo-DILI-Concern,inactive
564,4174,metyrapone,CC(C)(C(=O)c1cccnc1)c1cccnc1,226.110613068,vNo-DILI-Concern,inactive
565,441350,metyrosine,C[C@](N)(Cc1ccc(O)cc1)C(=O)O,195.089543276,vNo-DILI-Concern,inactive
566,4192,midazolam,Cc1ncc2n1-c1ccc(Cl)cc1C(c1ccccc1F)=NC2,325.078203316,vNo-DILI-Concern,inactive
567,4195,midodrine,COc1ccc(OC)c(C(O)CNC(=O)CN)c1,254.126657056,vNo-DILI-Concern,inactive
568,55245,mifepristone,CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C,429.26677936,vNo-DILI-Concern,inactive
569,441314,miglitol,OCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO,207.110672644,vNo-DILI-Concern,inactive
570,51634,miglustat,CCCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO,219.147058152,vNo-DILI-Concern,inactive
571,4201,minoxidil,N=c1nc(N2CCCCC2)cc(N)n1O,209.1276601,vNo-DILI-Concern,inactive
572,4211,mitotane,Clc1ccc(C(c2ccccc2Cl)C(Cl)Cl)cc1,317.95366104,vNo-DILI-Concern,inactive
573,5288826,morphine,CN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5,285.136493468,vNo-DILI-Concern,inactive
574,5284592,nabilone,CCCCCCC(C)(C)c1cc(O)c2c(c1)OC(C)(C)[C@@H]1CCC(=O)C[C@@H]21,372.266445012,vNo-DILI-Concern,inactive
575,5360630,nalbuphine,Oc1ccc2c3c1OC1[C@@H](O)CC[C@@]4(O)[C@@H](C2)N(CC2CCC2)CC[C@]314,357.194008344,vNo-DILI-Concern,inactive
576,5284596,naloxone,C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5,327.147058152,vNo-DILI-Concern,inactive
577,4454,neomycin,NCC1OC(OC2C(CO)OC(OC3C(O)C(N)CC(N)C3OC3OC(CN)C(O)C(O)C3N)C2O)C(N)C(O)C1O,614.312285532,vNo-DILI-Concern,inactive
578,41684,nitazoxanide,CC(=O)Oc1ccccc1C(=O)Nc1ncc([N+](=O)[O-])s1,307.026291388,vNo-DILI-Concern,inactive
579,4510,nitroglycerin,O=[N+]([O-])OCC(CO[N+](=O)[O-])O[N+](=O)[O-],227.00257874,vNo-DILI-Concern,inactive
580,439260,norepinephrine,NC[C@H](O)c1ccc(O)c(O)c1,169.073893212,vNo-DILI-Concern,inactive
581,541197,norethindrone acetate,C#CC1(OC(C)=O)CCC2C3CCC4=CC(=O)CCC4C3CCC21C,340.203844756,vNo-DILI-Concern,inactive
582,11953884,nystatin,CC1/C=C/C=C/CC/C=C/C=C/C=C/C=C/C(OC2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)CC(O)C(C(=O)O)C(O)CC(=O)CC(O)C(O)CCC(O)CC(O)CC(O)CC(=O)OC(C)C(C)C1O,925.50349994,vNo-DILI-Concern,inactive
583,4086,orciprenaline,CC(C)NCC(O)c1cc(O)cc(O)c1,211.120843404,vNo-DILI-Concern,inactive
584,4601,orphenadrine,Cc1ccccc1C(OCCN(C)C)c1ccccc1,269.177964356,vNo-DILI-Concern,inactive
585,4634,oxybutynin,CCN(CC)CC#CCOC(=O)C(O)(c1ccccc1)C1CCCCC1,357.230393852,vNo-DILI-Concern,inactive
586,5284603,oxycodone,COc1ccc2c3c1O[C@H]1C(=O)CC[C@@]4(O)[C@@H](C2)N(C)CC[C@]314,315.147058152,vNo-DILI-Concern,inactive
587,5284604,oxymorphone,CN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5,301.131408088,vNo-DILI-Concern,inactive
588,115237,paliperidone,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2O,426.206718944,vNo-DILI-Concern,inactive
589,11806,pamabrom,Cn1c(=O)c2[nH]c(Br)nc2n(C)c1=O,257.975237564,vNo-DILI-Concern,inactive
590,27350,pancuronium,CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@H](CC[C@@]4(C)[C@H]3C[C@H]([N+]3(C)CCCCC3)[C@@H]4OC(C)=O)[C@@]2(C)C[C@@H]1[N+]1(C)CCCCC1,572.4542112402,vNo-DILI-Concern,inactive
591,165580,paromomycin,NC[C@@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3N)[C@@H]2O)[C@H](N)[C@@H](O)[C@@H]1O,615.29630112,vNo-DILI-Concern,inactive
592,22879211,pegfilgrastim,COc1ccc(N(C)C)cc1CN[C@H]1CCCN[C@H]1c1ccccc1,339.231062548,vNo-DILI-Concern,inactive
593,37464,penbutolol,CC(C)(C)NC[C@H](O)COc1ccccc1C1CCCC1,291.219829168,vNo-DILI-Concern,inactive
594,6869,penicillin v,CC1(C)S[C@@H]2[C@H](NC(=O)COc3ccccc3)C(=O)N2[C@H]1C(=O)O,350.093642676,vNo-DILI-Concern,inactive
595,444007,pentagastrin,CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CCNC(=O)OCC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O,767.331247148,vNo-DILI-Concern,inactive
596,441278,pentazocine,CC(C)=CCN1CC[C@@]2(C)c3cc(O)ccc3C[C@@H]1[C@@H]2C,285.209264484,vNo-DILI-Concern,inactive
597,3053,pentetic acid,O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CCN(CC(=O)O)CC(=O)O,393.138343936,vNo-DILI-Concern,inactive
598,6432,perflutren,FC(F)(F)C(F)(F)C(F)(F)F,187.98722576,vNo-DILI-Concern,inactive
599,12460,phendimetrazine,CC1C(c2ccccc2)OCCN1C,191.131014164,vNo-DILI-Concern,inactive
600,4768,phenoxybenzamine,CC(COc1ccccc1)N(CCCl)Cc1ccccc1,303.138992004,vNo-DILI-Concern,inactive
601,5775,phentolamine,Cc1ccc(N(CC2=NCCN2)c2cccc(O)c2)cc1,281.152812228,vNo-DILI-Concern,inactive
602,5983,physostigmine,CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C,275.163376912,vNo-DILI-Concern,inactive
603,4812,phytonadione,CC(=CCC1=C(C)C(=O)c2ccccc2C1=O)CCCC(C)CCCC(C)CCCC(C)C,450.349780712,vNo-DILI-Concern,inactive
604,16362,pimozide,O=c1[nH]c2ccccc2n1C1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1,461.227868988,vNo-DILI-Concern,inactive
605,4828,pindolol,CC(C)NCC(O)COc1cccc2[nH]ccc12,248.15247788,vNo-DILI-Concern,inactive
606,65015,plerixafor,c1cc(CN2CCCNCCNCCCNCC2)ccc1CN1CCCNCCNCCCNCC1,502.447143728,vNo-DILI-Concern,inactive
607,4908,primaquine,COc1cc(NC(C)CCCN)c2ncccc2c1,259.168462292,vNo-DILI-Concern,inactive
608,4909,primidone,CCC1(c2ccccc2)C(=O)NCNC1=O,218.105527688,vNo-DILI-Concern,inactive
609,4919,procyclidine,OC(CCN1CCCC1)(c1ccccc1)C1CCCCC1,287.224914548,vNo-DILI-Concern,inactive
610,4934,propantheline,CC(C)[N+](C)(CCOC(=O)C1c2ccccc2Oc2ccccc21)C(C)C,368.2220202401,vNo-DILI-Concern,inactive
611,638678,protirelin,NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1,362.170253184,vNo-DILI-Concern,inactive
612,4976,protriptyline,CNCCCC1c2ccccc2C=Cc2ccccc21,263.167399672,vNo-DILI-Concern,inactive
613,7028,pseudoephedrine,CN[C@@H](C)[C@@H](O)c1ccccc1,165.1153641,vNo-DILI-Concern,inactive
614,708857,pyrantel,CN1CCCN=C1/C=C/c1cccs1,206.087769448,vNo-DILI-Concern,inactive
615,4991,pyridostigmine,CN(C)C(=O)Oc1ccc[n+](C)c1,181.0971540761,vNo-DILI-Concern,inactive
616,1054,pyridoxine,Cc1ncc(CO)c(CO)c1O,169.073893212,vNo-DILI-Concern,inactive
617,4999,quazepam,Fc1ccccc1C1=NCC(=S)N(CC(F)(F)F)c2ccc(Cl)cc21,386.026759912,vNo-DILI-Concern,inactive
618,5035,raloxifene,O=C(c1ccc(OCCN2CCCCC2)cc1)c1c(-c2ccc(O)cc2)sc2cc(O)ccc12,473.166079344,vNo-DILI-Concern,inactive
619,208902,ramelteon,CCC(=O)NCC[C@@H]1CCc2ccc3c(c21)CCO3,259.157228912,vNo-DILI-Concern,inactive
620,56959,ranolazine,COc1ccccc1OCC(O)CN1CCN(CC(=O)Nc2c(C)cccc2C)CC1,427.247106536,vNo-DILI-Concern,inactive
621,219024,regadenoson,CNC(=O)c1cnn(-c2nc(N)c3ncn([C@@H]4O[C@H](CO)[C@@H](O)[C@H]4O)c3n2)c1,390.140015676,vNo-DILI-Concern,inactive
622,5770,reserpine,COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5cc(OC)ccc5c4CCN3C[C@H]2C[C@@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)[C@@H]1OC,608.27338086,vNo-DILI-Concern,inactive
623,6759,riboflavin,Cc1cc2nc3c(=O)[nH]c(=O)nc-3n(C[C@@H](O)[C@@H](O)[C@@H](O)CO)c2cc1C,376.13828436,vNo-DILI-Concern,inactive
624,5071,rimantadine,CC(N)C12CC3CC(CC(C3)C1)C2,179.167399672,vNo-DILI-Concern,inactive
625,5078,rizatriptan,CN(C)CCc1c[nH]c2ccc(Cn3cncn3)cc12,269.164045608,vNo-DILI-Concern,inactive
626,441290,rocuronium,C=CC[N+]1([C@H]2C[C@H]3[C@@H]4CC[C@H]5C[C@H](O)[C@@H](N6CCOCC6)C[C@]5(C)[C@H]4CC[C@]3(C)[C@H]2OC(C)=O)CCCC1,529.3999845961,vNo-DILI-Concern,inactive
627,5352062,romidepsin,C/C=C1\NC(=O)[C@H]2CSSCC/C=C/[C@H](CC(=O)N[C@H](C(C)C)C(=O)N2)OC(=O)[C@H](C(C)C)NC1=O,540.207626872,vNo-DILI-Concern,inactive
628,2083,salbutamol,CC(C)(C)NCC(O)c1ccc(O)c(CO)c1,239.152143532,vNo-DILI-Concern,inactive
629,49800073,saxagliptin,N#C[C@@H]1C[C@@H]2C[C@@H]2N1C(=O)[C@@H](N)C12CC3CC(CC(O)(C3)C1)C2,315.19467704,vNo-DILI-Concern,inactive
630,5184,scopolamine,CN1C2CC(OC(=O)C(CO)c3ccccc3)CC1C1OC12,303.147058152,vNo-DILI-Concern,inactive
631,26757,selegiline,C#CCN(C)[C@H](C)Cc1ccccc1,187.136099544,vNo-DILI-Concern,inactive
632,23701736,sodium lactate,[13CH3]C(O)C(=O)[O-],90.0277724399,vNo-DILI-Concern,inactive
633,169893,Sodium polystyrene sulfonate,C=Cc1ccccc1S(=O)(=O)O,184.019415116,vNo-DILI-Concern,inactive
634,82170,sorbitol,OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO,182.079038168,vNo-DILI-Concern,inactive
635,19649,streptomycin,CN[C@@H]1[C@H](O[C@H]2[C@H](O[C@@H]3[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]3O)O[C@@H](C)[C@]2(O)C=O)O[C@@H](CO)[C@H](O)[C@H]1O,581.265669688,vNo-DILI-Concern,inactive
636,5314,succinylcholine,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,290.2194602802,vNo-DILI-Concern,inactive
637,6398588,sucralfate,O=S(=O)(O)OC[C@H]1O[C@@H](O[C@]2(COS(=O)(=O)O)O[C@H](OS(=O)(=O)O)[C@@H](OS(=O)(=O)O)[C@@H]2OS(=O)(=O)O)[C@H](OS(=O)(=O)O)[C@@H](OS(=O)(=O)O)[C@@H]1OS(=O)(=O)O,967.75508034,vNo-DILI-Concern,inactive
638,41693,sufentanil,CCC(=O)N(c1ccccc1)C1(COC)CCN(CCc2cccs2)CC1,386.2027992,vNo-DILI-Concern,inactive
639,6433091,tapentadol,CCC(c1cccc(O)c1)C(C)CN(C)C,221.177964356,vNo-DILI-Concern,inactive
640,5401,terazosin,COc1cc2nc(N3CCN(C(=O)C4CCCO4)CC3)nc(N)c2cc1OC,387.19065428,vNo-DILI-Concern,inactive
641,1125,tetrahydrobiopterin,CC(O)C(O)C1CNc2nc(N)[nH]c(=O)c2N1,241.11748934,vNo-DILI-Concern,inactive
642,2153,theophylline,Cn1c(=O)c2[nH]cnc2n(C)c1=O,180.064725496,vNo-DILI-Concern,inactive
643,1130,thiamine,Cc1ncc(C[n+]2csc(CCO)c2C)c(N)n1,265.1117585841,vNo-DILI-Concern,inactive
644,60937,tiludronate,O=P(O)(O)C(Sc1ccc(Cl)cc1)P(=O)(O)O,317.928359948,vNo-DILI-Concern,inactive
645,60947,tirofiban,CCCCS(=O)(=O)N[C@@H](Cc1ccc(OCCCCC2CCNCC2)cc1)C(=O)O,440.234493252,vNo-DILI-Concern,inactive
646,60774,tolterodine,Cc1ccc(O)c([C@@H](CCN(C(C)C)C(C)C)c2ccccc2)c1,325.240564612,vNo-DILI-Concern,inactive
647,60700,topotecan,CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3c(CN(C)C)c(O)ccc3nc2-1,421.163770836,vNo-DILI-Concern,inactive
648,5526,tranexamic acid,NCC1CCC(C(=O)O)CC1,157.11027872,vNo-DILI-Concern,inactive
649,71433,trientine hydrochloride,NCCNCCNCCN,146.153146576,vNo-DILI-Concern,inactive
650,5572,trihexyphenidyl,OC(CCN1CCCCC1)(c1ccccc1)C1CCCCC1,301.240564612,vNo-DILI-Concern,inactive
651,5282443,triprolidine,Cc1ccc(/C(=C\CN2CCCC2)c2ccccn2)cc1,278.178298704,vNo-DILI-Concern,inactive
652,3034812,trospium,O=C(OC1CC2CC[C@@H](C1)[N+]21CCCC1)C(O)(c1ccccc1)c1ccccc1,392.2220202401,vNo-DILI-Concern,inactive
653,5610,tyramine,NCCc1ccc(O)cc1,137.084063972,vNo-DILI-Concern,inactive
654,62819,urofollitropin,CCC(C)C1NC(=O)C(Cc2ccc(O)cc2)NC(=O)C(N)CSSCC(C(=O)N2CCCC2C(=O)NC(CC(C)C)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(C(C)O)NC1=O,979.42555852,vNo-DILI-Concern,inactive
655,39764,vecuronium,CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@H](CC[C@@]4(C)[C@H]3C[C@H]([N+]3(C)CCCCC3)[C@@H]4OC(C)=O)[C@@]2(C)C[C@@H]1N1CCCCC1,557.4312847241,vNo-DILI-Concern,inactive
656,13342,vinblastine,CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1,810.420379436,vNo-DILI-Concern,inactive
657,54678501,vitamin c,O=C1OC([C@@H](O)CO)C(=O)C1O,176.032087976,vNo-DILI-Concern,inactive
658,14985,vitamin e,Cc1c(C)c2c(c(C)c1O)CC[C@@](C)(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)O2,430.38108084,vNo-DILI-Concern,inactive
659,5311,vorinostat,O=C(CCCCCCC(=O)Nc1ccccc1)NO,264.1473925,vNo-DILI-Concern,inactive
660,5719,zaleplon,CCN(C(C)=O)c1cccc(-c2ccnc3c(C#N)cnn23)c1,305.1276601,vNo-DILI-Concern,inactive
